| Year |
Citation |
Score |
| 2024 |
Rampioni Vinciguerra GL, Capece M, Reggiani Bonetti L, Nigita G, Calore F, Rentsch S, Magistri P, Ballarin R, Di Benedetto F, Distefano R, Cirombella R, Vecchione A, Belletti B, Baldassarre G, Lovat F, ... Croce CM, et al. Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal Transduction and Targeted Therapy. 9: 31. PMID 38342897 DOI: 10.1038/s41392-024-01740-4 |
0.304 |
|
| 2023 |
Cataldo A, Cheung DG, Hagan JP, Fassan M, Sandhu-Deol S, Croce CM, Di Leva G, Iorio MV. Genetic Loss of miR-205 Causes Increased Mammary Gland Development. Non-Coding Rna. 10. PMID 38250804 DOI: 10.3390/ncrna10010004 |
0.354 |
|
| 2023 |
Ng A, Lovat F, Shih AJ, Ma Y, Pekarsky Y, DiCaro F, Crichton L, Sharma E, Yan XJ, Sun D, Song T, Zou YR, Will B, Croce CM, Chiorazzi N. Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state. Proceedings of the National Academy of Sciences of the United States of America. 120: e2308658120. PMID 37844234 DOI: 10.1073/pnas.2308658120 |
0.364 |
|
| 2023 |
Kim T, Croce CM. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Experimental & Molecular Medicine. PMID 37430087 DOI: 10.1038/s12276-023-01050-9 |
0.459 |
|
| 2023 |
Fong LY, Huebner K, Jing R, Smalley KJ, Brydges CR, Fiehn O, Farber JL, Croce CM. Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220334120. PMID 37155893 DOI: 10.1073/pnas.2220334120 |
0.317 |
|
| 2022 |
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, ... Croce CM, et al. Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell. PMID 36306794 DOI: 10.1016/j.ccell.2022.10.005 |
0.76 |
|
| 2022 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, ... ... Croce CM, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306793 DOI: 10.1016/j.ccell.2022.10.006 |
0.724 |
|
| 2022 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, ... ... Croce CM, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306791 DOI: 10.1016/j.ccell.2022.10.007 |
0.724 |
|
| 2022 |
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, ... ... Croce CM, et al. Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine. PMID 36195688 DOI: 10.1038/s41591-022-02044-2 |
0.656 |
|
| 2022 |
Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 17: e0267628. PMID 35443005 DOI: 10.1371/journal.pone.0267628 |
0.687 |
|
| 2021 |
Kudo M, Zalles N, Distefano R, Nigita G, Veneziano D, Gasparini P, Croce CM. Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells. Cell Death and Differentiation. PMID 34561554 DOI: 10.1038/s41418-021-00864-2 |
0.407 |
|
| 2021 |
Lampis A, Hahne JC, Gasparini P, Cascione L, Hedayat S, Vlachogiannis G, Murgia C, Fontana E, Edwards J, Horgan PG, Terracciano L, Sansom OJ, Martins CD, Kramer-Marek G, Croce CM, et al. MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer. Cell Death and Differentiation. PMID 34226680 DOI: 10.1038/s41418-021-00820-0 |
0.344 |
|
| 2021 |
Kim T, Croce CM. MicroRNA and ER stress in cancer. Seminars in Cancer Biology. PMID 33422566 DOI: 10.1016/j.semcancer.2020.12.025 |
0.434 |
|
| 2020 |
Sapienza MR, Fuligni F, Melle F, Tabanelli V, Indio V, Laginestra MA, Motta G, Mazzara S, Cerroni L, Pileri A, Facchetti F, Paulli M, Cascione L, Laganà A, Berti E, ... ... Croce CM, et al. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma. Hematological Oncology. 38: 831-833. PMID 33405278 DOI: 10.1002/Hon.2782 |
0.376 |
|
| 2020 |
Romano G, Nigita G, Calore F, Saviana M, Le P, Croce CM, Acunzo M, Nana-Sinkam P. MiR-124a Regulates Extracellular Vesicle Release by Targeting GTPase Rabs in Lung Cancer. Frontiers in Oncology. 10: 1454. PMID 32974168 DOI: 10.3389/Fonc.2020.01454 |
0.422 |
|
| 2020 |
Sheetz T, Mills J, Tessari A, Pawlikowski M, Braddom AE, Posid T, Zynger DL, James C, Embrione V, Parbhoo K, Foray C, Coppola V, Croce CM, Palmieri D. NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs. Cancers. 12. PMID 32664322 DOI: 10.3390/Cancers12071861 |
0.39 |
|
| 2020 |
Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D'Andrea A, Foulkes WD, Gaudino G, Groden JL, Henske EP, Hickson ID, Hwang PM, Kolodner RD, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nature Reviews. Cancer. PMID 32472073 DOI: 10.1038/S41568-020-0265-Y |
0.317 |
|
| 2020 |
Lovat F, Nigita G, Distefano R, Nakamura T, Gasparini P, Tomasello L, Fadda P, Ibrahimova N, Catricalà S, Palamarchuk A, Caligiuri MA, Gallì A, Malcovati L, Minden MD, Croce CM. Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 32424097 DOI: 10.1073/Pnas.2003597117 |
0.441 |
|
| 2020 |
Vicentini C, Calore F, Nigita G, Fadda P, Simbolo M, Sperandio N, Luchini C, Lawlor RT, Croce CM, Corbo V, Fassan M, Scarpa A. Exosomal miRNA signatures of pancreatic lesions. Bmc Gastroenterology. 20: 137. PMID 32375666 DOI: 10.1186/S12876-020-01287-Y |
0.344 |
|
| 2020 |
Khawaled S, Nigita G, Distefano R, Oster S, Suh SS, Smith Y, Khalaileh A, Peng Y, Croce CM, Geiger T, Seewaldt VL, Aqeilan RI. Pleiotropic tumor suppressor functions of WWOX antagonize metastasis. Signal Transduction and Targeted Therapy. 5: 43. PMID 32300104 DOI: 10.1038/S41392-020-0136-8 |
0.636 |
|
| 2020 |
Fong LY, Taccioli C, Palamarchuk A, Tagliazucchi GM, Jing R, Smalley KJ, Fan S, Altemus J, Fiehn O, Huebner K, Farber JL, Croce CM. Abrogation of esophageal carcinoma development in miR-31 knockout rats. Proceedings of the National Academy of Sciences of the United States of America. PMID 32123074 DOI: 10.1073/Pnas.1920333117 |
0.418 |
|
| 2020 |
Liang G, Meng W, Huang X, Zhu W, Yin C, Wang C, Fassan M, Yu Y, Kudo M, Xiao S, Zhao C, Zou P, Wang Y, Li X, Croce CM, et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 32041891 DOI: 10.1073/Pnas.1917531117 |
0.475 |
|
| 2020 |
Gangemi CMA, Alaimo S, Pulvirenti A, García-Viñuales S, Milardi D, Falanga AP, Fragalà ME, Oliviero G, Piccialli G, Borbone N, Ferro A, D'Urso A, Croce CM, Purrello R. Endogenous and artificial miRNAs explore a rich variety of conformations: a potential relationship between secondary structure and biological functionality. Scientific Reports. 10: 453. PMID 31949213 DOI: 10.1038/S41598-019-57289-8 |
0.438 |
|
| 2020 |
Farina NH, Scalia S, Adams CE, Hong D, Fritz AJ, Messier TL, Balatti V, Veneziano D, Lian JB, Croce CM, Stein GS, Stein JL. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer. Journal of Cellular Physiology. PMID 31919859 DOI: 10.1002/Jcp.29419 |
0.353 |
|
| 2020 |
Sapienza MR, Fuligni F, Melle F, Tabanelli V, Indio V, Pileri A, Cerroni L, Bacci F, Motta G, Laginestra MA, Mazzara S, Cascione L, Laganà A, Agostinelli C, Ferracin M, ... ... Croce C, et al. Abstract 1417: Development of a miRNA-based prediction tool to discriminate cutaneous blastic plasmacytoid dendritic cell neoplasm from cutaneous myeloid sarcoma Cancer Research. 80: 1417-1417. DOI: 10.1158/1538-7445.Am2020-1417 |
0.369 |
|
| 2019 |
La Ferlita A, Alaimo S, Veneziano D, Nigita G, Balatti V, Croce CM, Ferro A, Pulvirenti A. Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer. Database : the Journal of Biological Databases and Curation. 2019. PMID 31735953 DOI: 10.1093/Database/Baz115 |
0.353 |
|
| 2019 |
Veneziano D, Tomasello L, Balatti V, Palamarchuk A, Rassenti LZ, Kipps TJ, Pekarsky Y, Croce CM. Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 116: 24252-24258. PMID 31723042 DOI: 10.1073/Pnas.1913695116 |
0.359 |
|
| 2019 |
Luo Z, Zhang M, Cui R, Tili E, Kim T, Lee TJ, Peng Y, Croce C. A negative feedback regulatory loop between miR-138 and TP53 is mediated by USP10. Oncotarget. 10: 6288-6296. PMID 31695837 DOI: 10.18632/Oncotarget.27275 |
0.561 |
|
| 2019 |
Balatti V, Croce CM. MicroRNA dysregulation and multi-targeted therapy for cancer treatment. Advances in Biological Regulation. 100669. PMID 31640928 DOI: 10.1016/J.Jbior.2019.100669 |
0.468 |
|
| 2019 |
Casadei L, Calore F, Braggio DA, Zewdu A, Deshmukh AA, Fadda P, Lopez G, Wabitsch M, Song C, Leight JL, Grignol VP, Lev D, Croce CM, Pollock RE. MDM2 derived from dedifferentiated liposarcoma extracellular vesicles induces MMP2 production from preadipocytes. Cancer Research. PMID 31387924 DOI: 10.1158/0008-5472.Can-19-0203 |
0.324 |
|
| 2019 |
Serebrennikova OB, Paraskevopoulou MD, Aguado-Fraile E, Taraslia V, Ren W, Thapa G, Roper J, Du K, Croce CM, Tsichlis PN. The combination of knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. PMID 31239343 DOI: 10.1073/Pnas.1901465116 |
0.371 |
|
| 2019 |
Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Correction: Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. The Journal of Biological Chemistry. 294: 10018. PMID 31227623 DOI: 10.1074/Jbc.Aac119.009552 |
0.388 |
|
| 2019 |
Pagotto S, Veronese A, Soranno A, Balatti V, Ramassone A, Guanciali-Franchi PE, Palka G, Innocenti I, Autore F, Rassenti LZ, Kipps TJ, Mariani-Costantini R, Laurenti L, Croce CM, Visone R. HNRNPL Restrains Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia. Cancers. 11. PMID 31018621 DOI: 10.3390/Cancers11040575 |
0.364 |
|
| 2019 |
Tomasello L, Cluts L, Croce CM. Experimental Validation of MicroRNA Targets: Analysis of MicroRNA Targets Through Western Blotting. Methods in Molecular Biology (Clifton, N.J.). 1970: 341-353. PMID 30963502 DOI: 10.1007/978-1-4939-9207-2_19 |
0.382 |
|
| 2019 |
Tomasello L, Cluts L, Croce CM. Experimental Validation of MicroRNA Targets: Mutagenesis of Binding Regions. Methods in Molecular Biology (Clifton, N.J.). 1970: 331-339. PMID 30963501 DOI: 10.1007/978-1-4939-9207-2_18 |
0.356 |
|
| 2019 |
Tomasello L, Cluts L, Croce CM. Experimental Validation of MicroRNA Targets: Luciferase Reporter Assay. Methods in Molecular Biology (Clifton, N.J.). 1970: 315-330. PMID 30963500 DOI: 10.1007/978-1-4939-9207-2_17 |
0.373 |
|
| 2019 |
Veneziano D, Marceca GP, Di Bella S, Nigita G, Distefano R, Croce CM. Investigating miRNA-lncRNA Interactions: Computational Tools and Resources. Methods in Molecular Biology (Clifton, N.J.). 1970: 251-277. PMID 30963497 DOI: 10.1007/978-1-4939-9207-2_14 |
0.351 |
|
| 2019 |
Distefano R, Nigita G, Veneziano D, Romano G, Croce CM, Acunzo M. isoTar: Consensus Target Prediction with Enrichment Analysis for MicroRNAs Harboring Editing Sites and Other Variations. Methods in Molecular Biology (Clifton, N.J.). 1970: 211-235. PMID 30963495 DOI: 10.1007/978-1-4939-9207-2_12 |
0.38 |
|
| 2019 |
Druck T, Cheung DG, Park D, Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Aqeilan RI, Gaudio E, Okumura H, Iuliano R, Raso C, Green K, Huebner K, Croce CM. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells. Cell Death & Disease. 10: 147. PMID 30770797 DOI: 10.1038/S41419-019-1414-7 |
0.345 |
|
| 2019 |
Khawaled S, Suh SS, Abdeen SK, Monin J, Distefano R, Nigita G, Croce CM, Aqeilan RI. WWOX inhibits metastasis of triple-negative breast cancer cells via modulation of microRNAs. Cancer Research. PMID 30622118 DOI: 10.1158/0008-5472.Can-18-0614 |
0.647 |
|
| 2019 |
Pekarsky Y, Croce CM. Noncoding RNA genes in cancer pathogenesis. Advances in Biological Regulation. 71: 219-223. PMID 30611710 DOI: 10.1016/J.Jbior.2018.12.002 |
0.474 |
|
| 2019 |
Fassan M, Cui R, Gasparini P, Mescoli C, Guzzardo V, Vicentini C, Munari G, Loupakis F, Lonardi S, Braconi C, Scarpa M, D'Angelo E, Pucciarelli S, Angriman I, Agostini M, ... ... Croce CM, et al. miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis. Translational Oncology. 12: 282-291. PMID 30448733 DOI: 10.1016/J.Tranon.2018.10.013 |
0.416 |
|
| 2019 |
Zanesi N, Pekarsky Y, Trapasso F, Calin G, Croce CM. MicroRNAs in mouse models of lymphoid malignancies. Journal of Nucleic Acids Investigation. 1: 36-40. PMID 21666870 DOI: 10.4081/Jnai.2010.E8 |
0.477 |
|
| 2019 |
Zalles N, Gasparini P, Croce C. Abstract P6-05-07: The effects of microRNA modulation of polo-like kinase 1 in breast cancer cell lines Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-05-07 |
0.492 |
|
| 2019 |
Soliman S, Orlacchio A, Tessari A, Capece M, Visone R, Croce C, Palmieri D, Coppola V. Abstract 3514: RANBP9 presence affects levels of Tip60 and activated p53 in lung cancer cells in response to DNA damage Cancer Research. 79: 3514-3514. DOI: 10.1158/1538-7445.Am2019-3514 |
0.34 |
|
| 2019 |
Casadei L, Calore F, Deshmukh A, Zewdu A, Braggio DA, Fadda P, Wabitsch M, Lopez G, Leight J, Lev D, Croce CM, Pollock RE. Abstract 1891: OncogenicMDM2-containing exosomes promote pre-metastatic niche establishment Cancer Research. 79: 1891-1891. DOI: 10.1158/1538-7445.Am2019-1891 |
0.321 |
|
| 2019 |
Sapienza MR, Ferracin M, Fuligni F, Melle F, Motta G, Laginestra MA, Rossi M, Cascione L, Laganà A, Agostinelli C, Sabattini E, Pileri A, Croce CM, Pileri SA. Abstract 1805: Integrative analysis of microRNAs in blastic plasmacytoid dendritic cell neoplasm Cancer Research. 79: 1805-1805. DOI: 10.1158/1538-7445.Am2019-1805 |
0.488 |
|
| 2018 |
Pekarsky Y, Balatti V, Croce CM. BCL2 and miR-15/16: from gene discovery to treatment. Cell Death and Differentiation. 25: 21-26. PMID 31745319 DOI: 10.1038/cdd.2017.159 |
0.341 |
|
| 2018 |
Bertagnolo V, Grassilli S, Volinia S, Al-Qassab Y, Brugnoli F, Vezzali F, Lambertini E, Palomba M, Piubello Q, Orvieto E, Natali C, Piva MR, Croce CM, Capitani S. Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a. Molecular Carcinogenesis. PMID 30582225 DOI: 10.1002/Mc.22964 |
0.411 |
|
| 2018 |
Jeon YJ, Kim T, Park D, Nuovo GJ, Rhee S, Joshi P, Lee BK, Jeong J, Suh SS, Grotzke JE, Kim SH, Song J, Sim H, Kim Y, Peng Y, ... ... Croce CM, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nature Communications. 9: 5110. PMID 30504895 DOI: 10.1038/S41467-018-07561-8 |
0.688 |
|
| 2018 |
Lovat F, Fassan M, Sacchi D, Ranganathan P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G, Distefano R, Veneziano D, Dorrance AM, Garzon R, Croce CM. Knockout of both miR-15/16 loci induces acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 30478046 DOI: 10.1073/Pnas.1814980115 |
0.429 |
|
| 2018 |
Fong LY, Jing R, Smalley KJ, Wang ZX, Taccioli C, Fan S, Chen H, Alder H, Huebner K, Farber JL, Fiehn O, Croce CM. Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats. Proceedings of the National Academy of Sciences of the United States of America. PMID 30397150 DOI: 10.1073/Pnas.1813956115 |
0.304 |
|
| 2018 |
Balatti V, Oghumu S, Bottoni A, Maharry K, Cascione L, Fadda P, Parwani A, Croce C, Iwenofu OH. MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene. Head and Neck Pathology. 13: 344-354. PMID 30259272 DOI: 10.1007/S12105-018-0971-X |
0.444 |
|
| 2018 |
Croce CM, Calore F, Londhe P, Fadda P, Nigita G, Casadei L, Marceca GP, Fassan M, Lovat F, Gasparini P, Rizzotto L, Zanesi N, Jackson D, Mehta S, Nana-Sinkam P, et al. The TLR7/8/9 antagonist IMO-8503 inhibits cancer-induced cachexia. Cancer Research. PMID 30209066 DOI: 10.1158/0008-5472.Can-17-3878 |
0.414 |
|
| 2018 |
Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, La Perle K, Farina G, Cole S, ... ... Croce CM, et al. RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients. Oncogene. PMID 30076413 DOI: 10.1038/S41388-018-0424-8 |
0.325 |
|
| 2018 |
Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zamò A. MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. Oncotarget. 9: 29753-29771. PMID 30038718 DOI: 10.18632/Oncotarget.25707 |
0.424 |
|
| 2018 |
Pettit C, Webb A, Walston S, Chatterjee M, Chen W, Frankel W, Croce C, Williams TM. MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma. Oncotarget. 9: 28951-28964. PMID 29988972 DOI: 10.18632/Oncotarget.25652 |
0.404 |
|
| 2018 |
Nigita G, Distefano R, Veneziano D, Romano G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M, Nana-Sinkam P. Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer. Scientific Reports. 8: 10222. PMID 29976955 DOI: 10.1038/S41598-018-28528-1 |
0.395 |
|
| 2018 |
Awad H, Bratasz A, Nuovo G, Burry R, Meng X, Kelani H, Brown M, Ramadan ME, Williams J, Bouhliqah L, Popovich PG, Guan Z, Mcallister C, Corcoran SE, Kaspar B, ... ... Croce CM, et al. MiR-155 deletion reduces ischemia-induced paralysis in an aortic aneurysm repair mouse model: Utility of immunohistochemistry and histopathology in understanding etiology of spinal cord paralysis. Annals of Diagnostic Pathology. 36: 12-20. PMID 29966831 DOI: 10.1016/J.Anndiagpath.2018.06.002 |
0.354 |
|
| 2018 |
Baldassari F, Zerbinati C, Galasso M, Corrà F, Minotti L, Agnoletto C, Previati M, Croce CM, Volinia S. Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors. Frontiers in Genetics. 9: 174. PMID 29868122 DOI: 10.3389/Fgene.2018.00174 |
0.464 |
|
| 2018 |
Volinia S, Bertagnolo V, Grassilli S, Brugnoli F, Manfrini M, Galasso M, Scatena C, Mazzanti CM, Lessi F, Naccarato G, Caligo A, Bianchini E, Piubello Q, Orvieto E, Rugge M, ... ... Croce CM, et al. Levels of miR-126 and miR-218 are elevated in ductal carcinoma (DCIS) and inhibit malignant potential of DCIS derived cells. Oncotarget. 9: 23543-23553. PMID 29805754 DOI: 10.18632/Oncotarget.25261 |
0.452 |
|
| 2018 |
Malpeli G, Barbi S, Greco C, Zupo S, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Scarpa A, Zamò A. MicroRNA signatures and Foxp3 cell count correlate with relapse occurrence in follicular lymphoma. Oncotarget. 9: 19961-19979. PMID 29731996 DOI: 10.18632/Oncotarget.24987 |
0.41 |
|
| 2018 |
Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, Veneziano D, Nigita G, Shankaraiah RC, Portolani N, Carcoforo P, ... ... Croce CM, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 9: 15350-15364. PMID 29632649 DOI: 10.18632/Oncotarget.24601 |
0.413 |
|
| 2018 |
Pagotto S, Veronese A, Soranno A, Lanuti P, Marco MD, Russo MV, Ramassone A, Marchisio M, Simeone P, Franchi PEG, Palka G, Costantini RM, Croce CM, Visone R.
drives aneuploidy at early stages of cellular transformation. Oncotarget. 9: 13036-13047. PMID 29560129 DOI: 10.18632/Oncotarget.24437 |
0.352 |
|
| 2018 |
Martín-López J, Gasparini P, Coombes K, Croce CM, Boivin GP, Fishel R. Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention. Oncotarget. 9: 12554-12561. PMID 29560090 DOI: 10.18632/Oncotarget.23792 |
0.31 |
|
| 2018 |
Galasso M, Morrison C, Minotti L, Corrà F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D'Atri S, Alvino E, Previati M, ... ... Croce CM, et al. Loss of miR-204 expression is a key event in melanoma. Molecular Cancer. 17: 71. PMID 29523154 DOI: 10.1186/S12943-018-0819-8 |
0.735 |
|
| 2018 |
Ngankeu A, Ranganathan P, Havelange V, Nicolet D, Volinia S, Powell BL, Kolitz JE, Uy GL, Stone RM, Kornblau SM, Andreeff M, Croce CM, Bloomfield CD, Garzon R. Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia. Oncotarget. 9: 4354-4365. PMID 29435107 DOI: 10.18632/Oncotarget.23150 |
0.409 |
|
| 2018 |
Luo Z, Cui R, Tili E, Croce C. Friend or Foe: MicroRNAs in the p53 network. Cancer Letters. PMID 29330109 DOI: 10.1016/J.Canlet.2018.01.013 |
0.388 |
|
| 2018 |
Kim T, Croce CM. Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis. Cancer Letters. PMID 29306015 DOI: 10.1016/J.Canlet.2017.12.033 |
0.471 |
|
| 2018 |
Rossi M, Colecchia D, Ilardi G, Acunzo M, Nigita G, Sasdelli F, Celetti A, Strambi A, Staibano S, Croce CM, Chiariello M. MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors. Oncotarget. 7: 20981-98. PMID 26988910 DOI: 10.18632/Oncotarget.8044 |
0.342 |
|
| 2018 |
Bill M, Veneziano D, Kohlschmidt J, Mrózek K, Nigita G, Krantz MG, Nicolet D, Papaioannou D, Walker A, Brannan Z, Powell BL, Stone RM, Uy GL, Kolitz JE, Wang ES, ... ... Croce CM, et al. Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) Blood. 132: 89-89. DOI: 10.1182/Blood-2018-99-115270 |
0.302 |
|
| 2018 |
Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Broggini M, Farina G, Marabese M, Garassino MC, Croce C, et al. Abstract LB-245: Multiple DNA-damage response pathways are modulated by RANBP9 protein in NSCLC Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-245 |
0.351 |
|
| 2018 |
Embrione V, Scarpati M, Uzzel ZD, Ahmad R, Sury FAD, Sheetz TJ, Coppola V, Singh SM, Saxena AD, Croce CM, Palmieri D. Abstract 476: A human scFv as a tool to understand the biogenesis of a subset of oncogenic microRNAs Cancer Research. 78: 476-476. DOI: 10.1158/1538-7445.Am2018-476 |
0.42 |
|
| 2018 |
Tessari A, Pawlikowski M, Parbhoo K, Willetts O, Hernandez M, Nigita G, Braddom A, Mills JJ, Palmieri D, Croce CM. Abstract 473: miR-135b mediates gemcitabine sensitivity in breast cancer cells by modulating epithelial-to-mesenchymal transition and mTOR-signaling Cancer Research. 78: 473-473. DOI: 10.1158/1538-7445.Am2018-473 |
0.474 |
|
| 2018 |
Cheung DG, Buzzetti M, Croce CM, Leva Gd. Abstract 1850: CDK inhibitor PHA-848125 preferentially inhibits proliferation of triple negative breast cancer and synergizes with cisplatin Cancer Research. 78: 1850-1850. DOI: 10.1158/1538-7445.Am2018-1850 |
0.335 |
|
| 2018 |
Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, Perle KL, Farina G, Cole S, ... ... Croce CM, et al. Abstract A112: RanBP9 protects cells from genotoxic stress and increased expression is predictive of worse response to platinum in NSCLC patients Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A112 |
0.358 |
|
| 2017 |
Lai HH, Li JN, Wang MY, Huang HY, Croce CM, Sun HL, Lyu YJ, Kang JW, Chiu CF, Hung MC, Suzuki HI, Chen PS. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis. The Journal of Clinical Investigation. PMID 29251629 DOI: 10.1172/Jci89212 |
0.348 |
|
| 2017 |
Tili E, Michaille JJ, Piurowski V, Rigot B, Croce CM. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials. Current Opinion in Pharmacology. 37: 142-150. PMID 29154194 DOI: 10.1016/J.Coph.2017.10.010 |
0.385 |
|
| 2017 |
Fong LY, Jing R, Smalley KJ, Taccioli C, Fahrmann J, Barupal DK, Alder H, Farber JL, Fiehn O, Croce CM. Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia. Oncotarget. 8: 81910-81925. PMID 29137232 DOI: 10.18632/Oncotarget.18434 |
0.413 |
|
| 2017 |
Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R, Clarke P, Bosma E, Simbolo M, Scarpa A, Yu S, Cole R, Smyth E, Mateos JF, Begum R, ... ... Croce CM, et al. MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma. Gastroenterology. PMID 29113809 DOI: 10.1053/J.Gastro.2017.10.043 |
0.419 |
|
| 2017 |
Pekarsky Y, Balatti V, Croce CM. BCL2 and miR-15/16: from gene discovery to treatment. Cell Death and Differentiation. PMID 28984869 DOI: 10.1038/Cdd.2017.159 |
0.456 |
|
| 2017 |
Wei H, Cui R, Bahr J, Zanesi N, Luo Z, Meng W, Liang G, Croce CM. miR-130a deregulates PTEN and stimulates tumor growth. Cancer Research. PMID 28935812 DOI: 10.1158/0008-5472.Can-17-0530 |
0.451 |
|
| 2017 |
Rassenti LZ, Balatti V, Ghia EM, Palamarchuk A, Tomasello L, Fadda P, Pekarsky Y, Widhopf GF, Kipps TJ, Croce CM. MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 28923920 DOI: 10.1073/Pnas.1708264114 |
0.452 |
|
| 2017 |
Balatti V, Pekarsky Y, Croce CM. Role of the tRNA-Derived Small RNAs in Cancer: New Potential Biomarkers and Target for Therapy. Advances in Cancer Research. 135: 173-187. PMID 28882222 DOI: 10.1016/Bs.Acr.2017.06.007 |
0.395 |
|
| 2017 |
Drusco A, Croce CM. MicroRNAs and Cancer: A Long Story for Short RNAs. Advances in Cancer Research. 135: 1-24. PMID 28882219 DOI: 10.1016/Bs.Acr.2017.06.005 |
0.352 |
|
| 2017 |
Laganà A, Dirksen WP, Supsavhad W, Yilmaz AS, Ozer HG, Feller JD, Vala KA, Croce CM, Rosol TJ. Discovery and characterization of the feline miRNAome. Scientific Reports. 7: 9263. PMID 28835705 DOI: 10.1038/S41598-017-10164-W |
0.373 |
|
| 2017 |
D'Abundo L, Callegari E, Bresin A, Chillemi A, Elamin BK, Guerriero P, Huang X, Saccenti E, Hussein EMAA, Casciano F, Secchiero P, Zauli G, Calin GA, Russo G, Lee LJ, ... Croce CM, et al. Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. Oncogene. PMID 28783166 DOI: 10.1038/Onc.2017.269 |
0.47 |
|
| 2017 |
Song Y, Kilburn D, Song JH, Cheng Y, Saeui CT, Cheung DG, Croce CM, Yarema KJ, Meltzer SJ, Liu KJ, Wang TH. Determination of absolute expression profiles using multiplexed miRNA analysis. Plos One. 12: e0180988. PMID 28704432 DOI: 10.1371/Journal.Pone.0180988 |
0.453 |
|
| 2017 |
Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, ... ... Croce CM, et al. tsRNA signatures in cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 28696308 DOI: 10.1073/Pnas.1706908114 |
0.394 |
|
| 2017 |
Nana-Sinkam SP, Acunzo M, Croce CM, Wang K. Extracellular Vesicle Biology in the Pathogenesis of Lung Disease. American Journal of Respiratory and Critical Care Medicine. PMID 28678586 DOI: 10.1164/Rccm.201612-2457Pp |
0.31 |
|
| 2017 |
Croce CM. MicroRNA Dysregulation to Identify Novel Therapeutic Targets. Current Topics in Microbiology and Immunology. PMID 28653191 DOI: 10.1007/82_2017_34 |
0.466 |
|
| 2017 |
Croce CM, Casadei L, Calore F, Creighton CJ, Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio D, Bill KL, Fadda P, Lovat F, Lopez G, Gasparini P, Chen JL, et al. Exosome-derived miR-25-3p and miR-92a-3p stimulate liposarcoma progression. Cancer Research. PMID 28588009 DOI: 10.1158/0008-5472.Can-16-2984 |
0.407 |
|
| 2017 |
Papaioannou D, Shen C, Nicolet D, McNeil B, Bill M, Karunasiri M, Burke MH, Ozer HG, Yilmaz SA, Zitzer N, Behbehani GK, Oakes CC, Steiner DJ, Marcucci G, Powell BL, ... ... Croce CM, et al. Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 28533390 DOI: 10.1073/Pnas.1703142114 |
0.306 |
|
| 2017 |
Acunzo M, Romano G, Nigita G, Veneziano D, Fattore L, Laganà A, Zanesi N, Fadda P, Fassan M, Rizzotto L, Kladney R, Coppola V, Croce CM. Selective targeting of point-mutated KRAS through artificial microRNAs. Proceedings of the National Academy of Sciences of the United States of America. PMID 28484014 DOI: 10.1073/Pnas.1620562114 |
0.328 |
|
| 2017 |
Romano G, Veneziano D, Acunzo M, Croce CM. Small non-Coding RNA and Cancer. Carcinogenesis. PMID 28449079 DOI: 10.1093/Carcin/Bgx026 |
0.336 |
|
| 2017 |
Zhou JK, Zheng YZ, Liu XS, Gou Q, Ma R, Guo CL, Croce CM, Liu L, Peng Y. ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer. Oncotarget. PMID 28427197 DOI: 10.18632/Oncotarget.15860 |
0.328 |
|
| 2017 |
Ahn J, Park YJ, Chen P, Lee TJ, Jeon YJ, Croce CM, Suh Y, Hwang S, Kwon WS, Pang MG, Kim CH, Lee SS, Lee K. Comparative expression profiling of testis-enriched genes regulated during the development of spermatogonial cells. Plos One. 12: e0175787. PMID 28414809 DOI: 10.1371/Journal.Pone.0175787 |
0.34 |
|
| 2017 |
Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, et al. An integrated approach identifies mediators of local recurrence in Head & Neck Squamous Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28174235 DOI: 10.1158/1078-0432.Ccr-16-2814 |
0.304 |
|
| 2017 |
Fattore L, Costantini S, Malpicci D, Ruggiero CF, Ascierto PA, Croce CM, Mancini R, Ciliberto G. MicroRNAs in melanoma development and resistance to target therapy. Oncotarget. PMID 28118616 DOI: 10.18632/Oncotarget.14763 |
0.386 |
|
| 2017 |
Lee TJ, Yoo JY, Shu D, Li H, Zhang J, Yu JG, Jaime-Ramirez AC, Acunzo M, Romano G, Cui R, Sun HL, Luo Z, Old M, Kaur B, Guo P, ... Croce CM, et al. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28109960 DOI: 10.1016/J.Ymthe.2016.11.016 |
0.425 |
|
| 2017 |
Malpeli G, Barbi S, Zupo S, Tosadori G, Scardoni G, Bertolaso A, Sartoris S, Ugel S, Vicentini C, Fassan M, Adamo A, Krampera M, Scupoli MT, Croce CM, Scarpa A. Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53. Oncotarget. 8: 11809-11826. PMID 28107180 DOI: 10.18632/Oncotarget.14683 |
0.459 |
|
| 2017 |
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, ... ... Croce CM, et al. Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. The Journal of Experimental Medicine. PMID 28104811 DOI: 10.1084/Jem.2012095001172017C |
0.324 |
|
| 2017 |
Laganà A, Ferro A, Croce CM. Editorial: Bioinformatics of Non-Coding RNAs with Applications to Biomedicine: Recent Advances and Open Challenges. Frontiers in Bioengineering and Biotechnology. 3: 156-156. PMID 26501059 DOI: 10.3389/Fbioe.2015.00156 |
0.316 |
|
| 2017 |
Croce CM. Abstract SY32-01: The new genetics and treatment of CLL Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Sy32-01 |
0.467 |
|
| 2016 |
Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduction and Targeted Therapy. 1: 15004. PMID 29263891 DOI: 10.1038/Sigtrans.2015.4 |
0.425 |
|
| 2016 |
D'Avino C, Palmieri D, Braddom A, Zanesi N, James C, Cole S, Salvatore F, Croce CM, De Lorenzo C. A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy. Oncotarget. PMID 27894092 DOI: 10.18632/Oncotarget.13522 |
0.408 |
|
| 2016 |
Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, Kutay H, Lovat F, Vicentini C, Huang HL, Wang SW, ... ... Croce CM, et al. ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5. Cancer Cell. 30: 723-736. PMID 27846390 DOI: 10.1016/J.Ccell.2016.10.001 |
0.566 |
|
| 2016 |
Iorio MV, Croce CM. Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer. Cancer Research. 76: 6143-6145. PMID 27803102 DOI: 10.1158/0008-5472.Can-16-2637 |
0.387 |
|
| 2016 |
Mundy-Bosse BL, Scoville SD, Chen L, McConnell K, Mao HC, Ahmed EH, Zorko N, Harvey S, Cole J, Zhang X, Costinean S, Croce CM, Larkin K, Byrd JC, Vasu S, et al. MicroRNA-29b mediates altered innate immune development in acute leukemia. The Journal of Clinical Investigation. PMID 27775550 DOI: 10.1172/Jci85413 |
0.397 |
|
| 2016 |
Croce CM, Reed JC. Finally, An Apoptosis-Targeting Therapeutic for Cancer. Cancer Research. PMID 27694602 DOI: 10.1158/0008-5472.Can-16-1248 |
0.354 |
|
| 2016 |
Justiniano SE, McElroy JP, Yu L, Yilmaz AS, Coombes KR, Senter L, Nagy R, Wakely P, Volinia S, Vinco M, Giordano TJ, Croce CM, Saji M, Ringel MD. Genetic variants in thyroid cancer distant metastases. Endocrine-Related Cancer. PMID 27542854 DOI: 10.1530/Erc-16-0351 |
0.303 |
|
| 2016 |
Sattari A, Siddiqui H, Moshiri F, Ngankeu A, Nakamura T, Kipps TJ, Croce CM. Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias. Oncotarget. PMID 27527866 DOI: 10.18632/Oncotarget.11099 |
0.372 |
|
| 2016 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, ... ... Croce CM, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. 30: 349-351. PMID 27505674 DOI: 10.1016/J.Ccell.2016.07.007 |
0.738 |
|
| 2016 |
Fattore L, Mancini R, Acunzo M, Romano G, Laganà A, Pisanu ME, Malpicci D, Madonna G, Mallardo D, Capone M, Fulciniti F, Mazzucchelli L, Botti G, Croce CM, Ascierto PA, et al. miR-579-3p controls melanoma progression and resistance to target therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 27503895 DOI: 10.1073/Pnas.1607753113 |
0.429 |
|
| 2016 |
Croce CM. Genetics: Are circRNAs involved in cancer pathogenesis? Nature Reviews. Clinical Oncology. PMID 27458008 DOI: 10.1038/Nrclinonc.2016.113 |
0.324 |
|
| 2016 |
Leoncini PP, Bertaina A, Papaioannou D, Flotho C, Masetti R, Bresolin S, Menna G, Santoro N, Zecca M, Basso G, Nigita G, Veneziano D, Pagotto S, D'Ovidio K, Rota R, ... ... Croce CM, et al. MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment. Oncotarget. PMID 27447965 DOI: 10.18632/Oncotarget.10577 |
0.457 |
|
| 2016 |
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce CM, Yu J, Caligiuri MA, et al. Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27390350 DOI: 10.1158/1078-0432.Ccr-16-1003 |
0.304 |
|
| 2016 |
Nigita G, Acunzo M, Romano G, Veneziano D, Laganà A, Vitiello M, Wernicke D, Ferro A, Croce CM. microRNA editing in seed region aligns with cellular changes in hypoxic conditions. Nucleic Acids Research. PMID 27298257 DOI: 10.1093/Nar/Gkw532 |
0.389 |
|
| 2016 |
Balatti V, Acunzo M, Pekarky Y, Croce CM. Novel mechanisms of regulation of miRNAs in CLL. Trends in Cancer. 2: 134-143. PMID 27213184 DOI: 10.1016/J.Trecan.2016.02.005 |
0.452 |
|
| 2016 |
Gaudio E, Paduano F, Ngankeu A, Ortuso F, Lovat F, Pinton S, D'Agostino S, Zanesi N, Aqeilan RI, Campiglia P, Novellino E, Alcaro S, Croce CM, Trapasso F. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Oncotarget. PMID 27166255 DOI: 10.18632/Oncotarget.9179 |
0.312 |
|
| 2016 |
Pekarsky Y, Balatti V, Palamarchuk A, Rizzotto L, Veneziano D, Nigita G, Rassenti LZ, Pass HI, Kipps TJ, Liu CG, Croce CM. Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 27071132 DOI: 10.1073/Pnas.1604266113 |
0.46 |
|
| 2016 |
Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 29: 607-608. PMID 27070707 DOI: 10.1016/J.Ccell.2016.03.013 |
0.475 |
|
| 2016 |
Liu PP, Liu J, Jiang WQ, Carew JS, Ogasawara MA, Pelicano H, Croce CM, Estrov Z, Xu RH, Keating MJ, Huang P. Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline. Oncogene. PMID 27065330 DOI: 10.1038/Onc.2016.103 |
0.319 |
|
| 2016 |
Palmieri D, Scarpa M, Tessari A, Uka R, Amari F, Lee C, Richmond T, Foray C, Sheetz T, Braddom A, Burd CE, Parvin JD, Ludwig T, Croce CM, Coppola V. Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells. Oncotarget. PMID 26943034 DOI: 10.18632/Oncotarget.7813 |
0.329 |
|
| 2016 |
Fong LY, Taccioli C, Jing R, Smalley KJ, Alder H, Jiang Y, Fadda P, Farber JL, Croce CM. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency. Oncotarget. PMID 26918602 DOI: 10.18632/Oncotarget.7561 |
0.433 |
|
| 2016 |
Acunzo M, Croce CM. Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia. Clinical Chemistry. 62: 655-6. PMID 26908869 DOI: 10.1373/Clinchem.2015.240036 |
0.476 |
|
| 2016 |
Bresin A, D'Abundo L, Narducci MG, Fiorenza MT, Croce CM, Negrini M, Russo G. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia. Cell Death & Disease. 7: e2071. PMID 26821067 DOI: 10.1038/Cddis.2015.419 |
0.361 |
|
| 2016 |
Fiore D, Donnarumma E, Roscigno G, Iaboni M, Russo V, Affinito A, Adamo A, De Martino F, Quintavalle C, Romano G, Greco A, Soini Y, Brunetti A, Croce CM, Condorelli G. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS. Oncotarget. PMID 26799668 DOI: 10.18632/Oncotarget.6968 |
0.428 |
|
| 2016 |
Galimov A, Merry TL, Luca E, Rushing EJ, Mizbani A, Turcekova K, Hartung A, Croce CM, Ristow M, Krützfeldt J. MicroRNA-29a in Adult Muscle Stem Cells Controls Skeletal Muscle Regeneration During Injury and Exercise Downstream of Fibroblast Growth Factor-2. Stem Cells (Dayton, Ohio). 34: 768-80. PMID 26731484 DOI: 10.1002/Stem.2281 |
0.383 |
|
| 2016 |
Cataldo A, Cheung DG, Balsari A, Tagliabue E, Coppola V, Iorio MV, Palmieri D, Croce CM. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 7: 786-97. PMID 26623722 DOI: 10.18632/Oncotarget.6381 |
0.435 |
|
| 2016 |
Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, Bellan C, Rossi M, Sapienza MR, Laginestra MA, Etebari M, Rogena EA, Tumwine L, Tripodo C, Gibellini D, ... ... Croce CM, et al. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Oncotarget. 7: 224-40. PMID 26325594 DOI: 10.18632/Oncotarget.4399 |
0.357 |
|
| 2016 |
Tessari A, Testa I, Verzoni E, Nigita G, Colecchia M, Palmieri D, Grassi P, Maggi C, Martinetti A, De Braud FG, Croce CM, Procopio G. Gene-expression profiling of collecting duct carcinoma of the kidney. Journal of Clinical Oncology. 34: 540-540. DOI: 10.1200/Jco.2016.34.2_Suppl.540 |
0.353 |
|
| 2016 |
Balatti V, Palamarchuk A, Rizzotto L, Veneziano D, Nigita G, Liu C, Rassenti LZ, Kipps TJ, Croce CM, Pekarsky Y. Role of Ts-RNAs in CLL Blood. 128: 2016-2016. DOI: 10.1182/Blood.V128.22.2016.2016 |
0.399 |
|
| 2016 |
Acunzo M, Nigita G, Romano G, Veneziano D, Lagana A, Wernicke D, Ferro A, Croce C. Abstract LB-166: miRNA editing in seed region is in synergy with cellular changes in hypoxic conditions Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-166 |
0.418 |
|
| 2016 |
Casadei L, Creighton C, Batte K, Chelouche-Lev D, Croce CM, Pollock RE. Abstract 966: Circulating exosomal miRNAs as potential biomarker in liposarcoma Cancer Research. 76: 966-966. DOI: 10.1158/1538-7445.Am2016-966 |
0.404 |
|
| 2016 |
Fattore L, Acunzo M, Romano G, Laganà A, Malpicci D, Pisanu ME, Grimaldi AM, Fulciniti F, Croce CM, Mancini R, Ascierto PA, Ciliberto G. Abstract 1070: miR-579-3p is a novel master regulator of melanoma progression and drug resistance in metastatic melanoma Cancer Research. 76: 1070-1070. DOI: 10.1158/1538-7445.Am2016-1070 |
0.468 |
|
| 2015 |
Di Leva G, Cheung DG, Croce CM. miRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Review of Endocrinology & Metabolism. 10: 607-617. PMID 27721895 DOI: 10.1586/17446651.2015.1099430 |
0.757 |
|
| 2015 |
Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM. microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proceedings of the National Academy of Sciences of the United States of America. 112: 14924-9. PMID 26627242 DOI: 10.1073/Pnas.1520329112 |
0.418 |
|
| 2015 |
Roscigno G, Quintavalle C, Donnarumma E, Puoti I, Diaz-Lagares A, Iaboni M, Fiore D, Russo V, Todaro M, Romano G, Thomas R, Cortino G, Gaggianesi M, Esteller M, Croce CM, et al. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b. Oncotarget. PMID 26556862 DOI: 10.18632/Oncotarget.5979 |
0.441 |
|
| 2015 |
Tarighat SS, Santhanam R, Frankhouser D, Radomska HS, Lai H, Anghelina M, Wang H, Huang X, Alinari L, Walker A, Caligiuri MA, Croce CM, Li L, Garzon R, Li C, et al. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia. PMID 26536822 DOI: 10.1038/Leu.2015.308 |
0.426 |
|
| 2015 |
Tili E, Chiabai M, Palmieri D, Brown M, Cui R, Fernandes C, Richmond T, Kim T, Sheetz T, Sun HL, Lagana A, Veneziano D, Volinia S, Rassenti L, Kipps T, ... ... Croce CM, et al. Quaking and miR-155 interactions in inflammation and leukemogenesis. Oncotarget. PMID 26337206 DOI: 10.18632/Oncotarget.5248 |
0.551 |
|
| 2015 |
Lovat F, Fassan M, Gasparini P, Rizzotto L, Cascione L, Pizzi M, Vicentini C, Balatti V, Palmieri D, Costinean S, Croce CM. miR-15b/16-2 deletion promotes B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. 112: 11636-41. PMID 26324892 DOI: 10.1073/Pnas.1514954112 |
0.425 |
|
| 2015 |
Cui R, Kim T, Fassan M, Meng W, Sun HL, Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, Liang G, Zhang YK, Chakravarti A, Croce CM. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. PMID 26307684 DOI: 10.18632/Oncotarget.5224 |
0.583 |
|
| 2015 |
Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley KJ, Selmi T, Naidu S, Farber JL, Croce CM, Fong LY. Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. Journal of the National Cancer Institute. 107. PMID 26286729 DOI: 10.1093/Jnci/Djv220 |
0.733 |
|
| 2015 |
Drusco A, Bottoni A, Laganà A, Acunzo M, Fassan M, Cascione L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder H, Carosi MA, Ammirati M, Gherardi S, Luscrì M, ... ... Croce CM, et al. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget. 6: 20829-39. PMID 26246487 DOI: 10.18632/Oncotarget.4096 |
0.33 |
|
| 2015 |
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan M, Jeon YJ, Li B, Vicentini C, Peng Y, Lee TJ, Luo Z, Liu L, Xu D, Tili E, ... ... Croce CM, et al. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 26187928 DOI: 10.1073/Pnas.1502068112 |
0.598 |
|
| 2015 |
Palmieri D, Richmond T, Piovan C, Sheetz T, Zanesi N, Troise F, James C, Wernicke D, Nyei F, Gordon TJ, Consiglio J, Salvatore F, Coppola V, Pichiorri F, De Lorenzo C, ... Croce CM, et al. Human anti-nucleolin recombinant immunoagent for cancer therapy. Proceedings of the National Academy of Sciences of the United States of America. 112: 9418-23. PMID 26170308 DOI: 10.1073/Pnas.1507087112 |
0.429 |
|
| 2015 |
Joshi P, Jeon YJ, Laganà A, Middleton J, Secchiero P, Garofalo M, Croce CM. MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proceedings of the National Academy of Sciences of the United States of America. 112: 8650-5. PMID 26124099 DOI: 10.1073/Pnas.1500886112 |
0.442 |
|
| 2015 |
Acunzo M, Croce CM. MicroRNA in Cancer and Cachexia--A Mini-Review. The Journal of Infectious Diseases. 212: S74-7. PMID 26116737 DOI: 10.1093/Infdis/Jiv197 |
0.41 |
|
| 2015 |
Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 10: e0131729. PMID 26110899 DOI: 10.1371/journal.pone.0131729 |
0.691 |
|
| 2015 |
Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Russo G, Negrini M. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. PMID 26090867 DOI: 10.18632/Oncotarget.4415 |
0.46 |
|
| 2015 |
Jeon YJ, Middleton J, Kim T, Laganà A, Piovan C, Secchiero P, Nuovo GJ, Cui R, Joshi P, Romano G, Di Leva G, Lee BK, Sun HL, Kim Y, Fadda P, ... ... Croce CM, et al. A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: E3355-64. PMID 26080425 DOI: 10.1073/Pnas.1504630112 |
0.772 |
|
| 2015 |
Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS, Ozer HG, Hoellarbauer P, Khalife J, Hill EB, Yadav M, Bolon BN, Lee RJ, Lee LJ, Croce CM, et al. Targeting leukemia stem cells in vivo with ANTAGOMIR-126 nanoparticles in acute myeloid leukemia. Leukemia. PMID 26055302 DOI: 10.1038/Leu.2015.139 |
0.429 |
|
| 2015 |
Cushing L, Costinean S, Xu W, Jiang Z, Madden L, Kuang P, Huang J, Weisman A, Hata A, Croce CM, Lü J. Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature. Plos Genetics. 11: e1005238. PMID 26020233 DOI: 10.1371/Journal.Pgen.1005238 |
0.435 |
|
| 2015 |
Kim T, Cui R, Jeon YJ, Fadda P, Alder H, Croce CM. MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression. Oncotarget. 6: 18780-9. PMID 26003165 DOI: 10.18632/Oncotarget.3909 |
0.512 |
|
| 2015 |
Fedele M, Visone R, Martino ID, Palmieri D, Valentino T, Esposito F, Klein-Szanto A, Arra C, Ciarmiello A, Croce CM, Fusco A. Retraction notice to “Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice” [Eur J Cancer 47 (2011) 470–478] European Journal of Cancer. 51: 789. PMID 25977969 DOI: 10.1016/J.Ejca.2015.03.001 |
0.33 |
|
| 2015 |
Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J, Wang H, Wu YZ, Alachkar H, Anghelina M, Dorrance A, Curfman J, Bloomfield CD, Medeiros BC, Perrotti D, ... ... Croce CM, et al. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Leukemia. PMID 25971362 DOI: 10.1038/leu.2015.106 |
0.315 |
|
| 2015 |
McIlhatton MA, Murnan K, Carson D, Boivin GP, Croce CM, Groden J. Genetic Manipulation of Homologous Recombination In Vivo Attenuates Intestinal Tumorigenesis. Cancer Prevention Research (Philadelphia, Pa.). 8: 650-6. PMID 25908507 DOI: 10.1158/1940-6207.Capr-15-0001-T |
0.323 |
|
| 2015 |
Balatti V, Pekarky Y, Croce CM. Role of microRNA in chronic lymphocytic leukemia onset and progression. Journal of Hematology & Oncology. 8: 12. PMID 25886051 DOI: 10.1186/S13045-015-0112-X |
0.438 |
|
| 2015 |
Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget. 6: 14766-76. PMID 25885522 DOI: 10.18632/Oncotarget.3632 |
0.334 |
|
| 2015 |
Burocchi A, Pittoni P, Tili E, Rigoni A, Costinean S, Croce CM, Colombo MP. Regulated Expression of miR-155 is Required for iNKT Cell Development. Frontiers in Immunology. 6: 140. PMID 25870598 DOI: 10.3389/Fimmu.2015.00140 |
0.448 |
|
| 2015 |
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget. 6: 4920-35. PMID 25749032 DOI: 10.18632/Oncotarget.3025 |
0.411 |
|
| 2015 |
Zhou Q, Yang L, Larson S, Basra S, Merwat S, Tan A, Croce C, Verne GN. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. PMID 25681400 DOI: 10.1136/Gutjnl-2013-306464 |
0.433 |
|
| 2015 |
Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H, Croce CM. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. Journal of the National Cancer Institute. 107. PMID 25663692 DOI: 10.1093/Jnci/Dju505 |
0.493 |
|
| 2015 |
Balatti V, Rizzotto L, Miller C, Palamarchuk A, Fadda P, Pandolfo R, Rassenti LZ, Hertlein E, Ruppert AS, Lozanski A, Lozanski G, Kipps TJ, Byrd JC, Croce CM, Pekarsky Y. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 112: 2169-74. PMID 25646413 DOI: 10.1073/Pnas.1500010112 |
0.459 |
|
| 2015 |
Chen K, Yang D, Li X, Sun B, Song F, Cao W, Brat DJ, Gao Z, Li H, Liang H, Zhao Y, Zheng H, Li M, Buckner J, Patterson SD, ... ... Croce CM, et al. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proceedings of the National Academy of Sciences of the United States of America. 112: 1107-12. PMID 25583476 DOI: 10.1073/Pnas.1422640112 |
0.302 |
|
| 2015 |
Laganà A, Veneziano D, Russo F, Pulvirenti A, Giugno R, Croce CM, Ferro A. Computational design of artificial RNA molecules for gene regulation. Methods in Molecular Biology (Clifton, N.J.). 1269: 393-412. PMID 25577393 DOI: 10.1007/978-1-4939-2291-8_25 |
0.391 |
|
| 2015 |
Iacovelli S, Hug E, Bennardo S, Duehren-von Minden M, Gobessi S, Rinaldi A, Suljagic M, Bilbao D, Bolasco G, Eckl-Dorna J, Niederberger V, Autore F, Sica S, Laurenti L, Wang H, ... ... Croce CM, et al. Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. Blood. 125: 1578-88. PMID 25564405 DOI: 10.1182/Blood-2014-07-587790 |
0.31 |
|
| 2015 |
Garofalo M, Croce CM. Role of microRNAs in maintaining cancer stem cells. Advanced Drug Delivery Reviews. 81: 53-61. PMID 25446141 DOI: 10.1016/J.Addr.2014.11.014 |
0.377 |
|
| 2015 |
Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer--a brief overview. Advances in Biological Regulation. 57: 1-9. PMID 25294678 DOI: 10.1016/J.Jbior.2014.09.013 |
0.399 |
|
| 2015 |
Zhou Q, Costinean S, Croce CM, Brasier AR, Merwat S, Larson SA, Basra S, Verne GN. MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability. Gastroenterology. 148: 158-169.e8. PMID 25277410 DOI: 10.1053/J.Gastro.2014.09.037 |
0.38 |
|
| 2015 |
Pekarsky Y, Croce CM. Role of miR-15/16 in CLL Cell Death and Differentiation. 22: 6-11. PMID 24971479 DOI: 10.1038/Cdd.2014.87 |
0.447 |
|
| 2015 |
Kapinas K, Kim H, Mandeville M, Martin-Buley LA, Croce CM, Lian JB, van Wijnen AJ, Stein JL, Altieri DC, Stein GS. microRNA-mediated survivin control of pluripotency. Journal of Cellular Physiology. 230: 63-70. PMID 24891298 DOI: 10.1002/Jcp.24681 |
0.459 |
|
| 2015 |
Tili E, Chiabai M, Palmieri D, Brown M, Cui R, Fernandes C, Richmond T, Kim T, Sheetz T, Sun HL, Lagana A, Veneziano D, Volinia S, Rassenti L, Kipps T, ... ... Croce CM, et al. Quaking and miR-155 interactions in inflammation and leukemogenesis Oncotarget. 6: 24599-24610. DOI: 10.18632/oncotarget.5248 |
0.485 |
|
| 2015 |
Zitzer NC, Ranganathan P, Dickinson BA, Jackson AL, Rodman DM, Croce CM, Marcucci G, Garzon R. Preclinical Development of LNA Antimir-155 (MRG-106) in Acute Myeloid Leukemia Blood. 126: 3802-3802. DOI: 10.1182/Blood.V126.23.3802.3802 |
0.438 |
|
| 2015 |
Leoncini PP, Bertaina A, Papaioannou D, Flotho C, Masetti R, Bresolin S, Menna G, Santoro N, Zecca M, Basso G, Nigita G, Pagotto S, D'Ovidio K, Rota R, Croce CM, et al. Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML) Blood. 126: 2851-2851. DOI: 10.1182/Blood.V126.23.2851.2851 |
0.428 |
|
| 2015 |
Scoville S, Mundy-Bosse B, Zhang M, Chen L, Sanderson R, Hughes T, Garzon R, Mishra A, Costinean S, Croce CM, Freud AG, Caligiuri MA. Microrna 29b Mediates Immune Evasion of Natural Killer Cells in Acute Myeloid Leukemia Blood. 126: 207-207. DOI: 10.1182/Blood.V126.23.207.207 |
0.439 |
|
| 2015 |
Croce CM. Abstract IA05: Novel function of microRNAs. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-Ia05 |
0.5 |
|
| 2015 |
Richmond TK, Tili E, Brown M, Chiabai M, Palmieri D, Cui R, Sheetz T, Croce CM. Abstract LB-289: Interaction between miR-155 and Quaking in the innate immune response and leukemia Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-289 |
0.458 |
|
| 2015 |
Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Negrini M, Russo G. Abstract 3974: A preclinical study for miR181b as therapeutic in Eu-TCL1FL-tg mouse model for CLL Cancer Research. 75: 3974-3974. DOI: 10.1158/1538-7445.Am2015-3974 |
0.451 |
|
| 2015 |
Fiore D, Quintavalle C, Donnarumma E, Roscigno G, Iaboni M, Russo V, Adamo A, Martino FD, Greco A, Romano G, Ylermi S, Brunetti A, Croce CM, Condorelli G. Abstract 3126: Survival in glioblastoma cancer patients is predicted by miR-340, that regulates key cancer hallmarks by inhibiting NRAS Cancer Research. 75: 3126-3126. DOI: 10.1158/1538-7445.Am2015-3126 |
0.5 |
|
| 2015 |
Damavandi MD, Braconi C, Cascione L, Lampis A, Hahne J, Murgia C, Ghidini M, Nyamundanda G, Sadanandam A, Croce C, Sansom O, Valeri N. Abstract 3083: Global gene expression profiling of mice tumor-derived organoids identifies key microRNAs and metabolic genes involved in CRC progression Cancer Research. 75: 3083-3083. DOI: 10.1158/1538-7445.Am2015-3083 |
0.447 |
|
| 2015 |
Braddom A, Richmond T, Sheetz T, Reese E, Tessari A, Tober K, Burd CE, Lorenzo CD, Martin EW, Coppola V, Tweedle MF, Oberyszyn T, Croce CM, Palmieri D. Abstract C171: Human anti-Nucleolin recombinant immunoagents as new potential tools for melanoma treatment Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C171 |
0.455 |
|
| 2015 |
Tessari A, Palmieri D, Nigita G, Veneziano D, Cresta S, Paolini B, Cona MS, Vargo T, Reese E, Sheetz T, Coppola V, Braud FD, Croce CM. Abstract C17: Role of miR-135b in gemcitabine sensitivity for metastatic breast cancer patients Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C17 |
0.469 |
|
| 2015 |
Richmond TK, Tili E, Chiabai M, Palmieri D, Brown M, Croce C. Functional Interaction of Mir-155, a Pro-Inflammatory microRNA, and Quaking in the Innate Immune Response Journal of Allergy and Clinical Immunology. 135: AB97. DOI: 10.1016/J.Jaci.2014.12.1252 |
0.355 |
|
| 2014 |
Laganà A, Shasha D, Croce CM. Synthetic RNAs for Gene Regulation: Design Principles and Computational Tools. Frontiers in Bioengineering and Biotechnology. 2: 65. PMID 25566532 DOI: 10.3389/Fbioe.2014.00065 |
0.32 |
|
| 2014 |
Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan PS, Mrózek K, Bucci D, Carroll AJ, Baer MR, Wetzler M, Carter TH, Powell BL, Kolitz JE, Moore JO, ... ... Croce CM, et al. Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 111: 18679-84. PMID 25512507 DOI: 10.1073/Pnas.1422050112 |
0.302 |
|
| 2014 |
Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, Sapienza MR, Motta G, Gazzola A, Mannu C, Sabattini E, Bacci F, Tabanelli V, Sacchetti CA, Barrese TZ, ... ... Croce CM, et al. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood Cancer Journal. 4: 259. PMID 25382608 DOI: 10.1038/Bcj.2014.78 |
0.388 |
|
| 2014 |
Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, et al. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6: 76. PMID 25352916 DOI: 10.1186/S13073-014-0076-4 |
0.303 |
|
| 2014 |
Suh SS, Yoo JY, Cui R, Kaur B, Huebner K, Lee TK, Aqeilan RI, Croce CM. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. Plos Genetics. 10: e1004652. PMID 25340791 DOI: 10.1371/Journal.Pgen.1004652 |
0.639 |
|
| 2014 |
Nana-Sinkam SP, Croce CM. MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use. Genome Biology. 15: 445. PMID 25315999 DOI: 10.1186/S13059-014-0445-8 |
0.376 |
|
| 2014 |
Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Garzon ME, Di Leva G, Gasparini P, Dama P, ... ... Croce CM, et al. Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. Journal of the National Cancer Institute. 106. PMID 25306216 DOI: 10.1093/Jnci/Dju324 |
0.709 |
|
| 2014 |
Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S, Bottoni A, Rosito IA, Liu CG, Burch A, Acunzo M, Pekarsky Y, ... ... Croce CM, et al. MicroRNA profiles discriminate among colon cancer metastasis. Plos One. 9: e96670. PMID 24921248 DOI: 10.1371/Journal.Pone.0096670 |
0.72 |
|
| 2014 |
Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, Messer K, Calin GA, Croce CM, Kipps TJ. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 124: 546-54. PMID 24914134 DOI: 10.1182/Blood-2014-03-559690 |
0.434 |
|
| 2014 |
Wei H, Wang C, Croce CM, Guan JL. p62/SQSTM1 synergizes with autophagy for tumor growth in vivo. Genes & Development. 28: 1204-16. PMID 24888590 DOI: 10.1101/Gad.237354.113 |
0.306 |
|
| 2014 |
Acunzo M, Romano G, Wernicke D, Balatti V, Rassenti LZ, dell'Aquila M, Kipps TJ, Pekarsky Y, Croce CM. Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene. Blood. 124: 259-62. PMID 24855209 DOI: 10.1182/Blood-2014-02-554675 |
0.32 |
|
| 2014 |
Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, Paone A, Cascione L, Sumani KM, Veronese A, Fabbri M, ... ... Croce CM, et al. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 25: 469-83. PMID 24735923 DOI: 10.1016/J.Ccr.2014.03.006 |
0.451 |
|
| 2014 |
Olivo-Marston SE, Hursting SD, Perkins SN, Schetter A, Khan M, Croce C, Harris CC, Lavigne J. Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and MicroRNA expression Plos One. 9. PMID 24732966 DOI: 10.1371/Journal.Pone.0094765 |
0.42 |
|
| 2014 |
Veronese A, Pepe F, Chiacchia J, Pagotto S, Lanuti P, Veschi S, Di Marco M, D'Argenio A, Innocenti I, Vannata B, Autore F, Marchisio M, Wernicke D, Verginelli F, Leone G, ... ... Croce CM, et al. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. Leukemia. 29: 86-95. PMID 24732594 DOI: 10.1038/Leu.2014.139 |
0.405 |
|
| 2014 |
Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre G. Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget. 5: 1185-97. PMID 24727437 DOI: 10.18632/Oncotarget.1803 |
0.444 |
|
| 2014 |
Zappasodi R, Cavanè A, Iorio MV, Tortoreto M, Guarnotta C, Ruggiero G, Piovan C, Magni M, Zaffaroni N, Tagliabue E, Croce CM, Zunino F, Gianni AM, Di Nicola M. Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas. International Journal of Cancer. 135: 2034-45. PMID 24648290 DOI: 10.1002/Ijc.28852 |
0.377 |
|
| 2014 |
Gasparini P, Cascione L, Fassan M, Lovat F, Guler G, Balci S, Irkkan C, Morrison C, Croce CM, Shapiro CL, Huebner K. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget. 5: 1174-84. PMID 24632568 DOI: 10.18632/Oncotarget.1682 |
0.455 |
|
| 2014 |
Laganà A, Acunzo M, Romano G, Pulvirenti A, Veneziano D, Cascione L, Giugno R, Gasparini P, Shasha D, Ferro A, Croce CM. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs. Nucleic Acids Research. 42: 5416-25. PMID 24627222 DOI: 10.1093/Nar/Gku202 |
0.437 |
|
| 2014 |
He WA, Calore F, Londhe P, Canella A, Guttridge DC, Croce CM. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proceedings of the National Academy of Sciences of the United States of America. 111: 4525-9. PMID 24616506 DOI: 10.1073/Pnas.1402714111 |
0.432 |
|
| 2014 |
Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K, Croce CM. Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proceedings of the National Academy of Sciences of the United States of America. 111: 4536-41. PMID 24616504 DOI: 10.1073/Pnas.1402604111 |
0.415 |
|
| 2014 |
Havelange V, Ranganathan P, Geyer S, Nicolet D, Huang X, Yu X, Volinia S, Kornblau SM, Andreeff M, Croce CM, Marcucci G, Bloomfield CD, Garzon R. Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML. Blood. 123: 2412-5. PMID 24596420 DOI: 10.1182/Blood-2013-10-532374 |
0.409 |
|
| 2014 |
Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, Park JK, Fadda P, Tili E, Nakanishi H, Huh MI, Kim SH, Cho JH, Sung BH, Peng Y, ... ... Croce CM, et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proceedings of the National Academy of Sciences of the United States of America. 111: 4173-8. PMID 24594601 DOI: 10.1073/Pnas.1400350111 |
0.48 |
|
| 2014 |
Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C, Paisie C, Lovat F, Morrison C, Zhang J, Scarpa A, Croce CM, Shapiro CL, Huebner K. Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. Plos One. 9: e88525. PMID 24505496 DOI: 10.1371/Journal.Pone.0088525 |
0.319 |
|
| 2014 |
Sapienza MR, Fuligni F, Agostinelli C, Tripodo C, Righi S, Laginestra MA, Pileri A, Mancini M, Rossi M, Ricci F, Gazzola A, Melle F, Mannu C, Ulbar F, Arpinati M, ... ... Croce CM, et al. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia. 28: 1606-16. PMID 24504027 DOI: 10.1182/Blood.V122.21.2502.2502 |
0.339 |
|
| 2014 |
Garofalo M, Leva GD, Croce CM. MicroRNAs as anti-cancer therapy. Current Pharmaceutical Design. 20: 5328-35. PMID 24479801 DOI: 10.2174/1381612820666140128211346 |
0.441 |
|
| 2014 |
Buchsbaum DJ, Croce CM. Will detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer? Jama. 311: 363-5. PMID 24449314 DOI: 10.1001/Jama.2013.284665 |
0.354 |
|
| 2014 |
Lovat F, Ishii H, Schiappacassi M, Fassan M, Barbareschi M, Galligioni E, Gasparini P, Baldassarre G, Croce CM, Vecchione A. LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. Oncotarget. 5: 970-7. PMID 24448468 DOI: 10.18632/Oncotarget.1630 |
0.342 |
|
| 2014 |
Gomez GG, Volinia S, Croce CM, Zanca C, Li M, Emnett R, Gutmann DH, Brennan CW, Furnari FB, Cavenee WK. Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Research. 74: 1429-39. PMID 24436148 DOI: 10.1158/0008-5472.Can-13-2117 |
0.396 |
|
| 2014 |
Widhopf GF, Cui B, Ghia EM, Chen L, Messer K, Shen Z, Briggs SP, Croce CM, Kipps TJ. ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 793-8. PMID 24379361 DOI: 10.1182/Blood.V122.21.868.868 |
0.361 |
|
| 2014 |
Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, ... ... Croce CM, et al. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma. Oncogene. 33: 5319-31. PMID 24240684 DOI: 10.1038/Onc.2013.476 |
0.436 |
|
| 2014 |
Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annual Review of Pathology. 9: 287-314. PMID 24079833 DOI: 10.1146/Annurev.Med.59.053006.104707 |
0.735 |
|
| 2014 |
Collins AL, Wojcik S, Liu J, Frankel WL, Alder H, Yu L, Schmittgen TD, Croce CM, Bloomston M. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Annals of Surgical Oncology. 21: 133-8. PMID 24046106 DOI: 10.1245/S10434-013-3240-Y |
0.414 |
|
| 2014 |
McClanahan F, Calore F, Zanesi N, Gribben JG, Croce CM. Aberrant PD-L1 Expression in CLL As a Result of Adaptive Immune Resistance Mediated By Tumor-Secreted Circulating miRNA Binding to Toll-like Receptor 7 Blood. 124: 716-716. DOI: 10.1182/Blood.V124.21.716.716 |
0.369 |
|
| 2014 |
Lampis A, Murgia C, Paulus-Hock V, Fassan M, Edwards J, Horgan P, Sansom O, Terracciano L, Karin M, Croce C, Braconi C, Valeri N. Abstract 976: Junctional adhesion molecule-A (JAM-A) expression is downmodulated by miR-21 during colorectal cancer progression Cancer Research. 74: 976-976. DOI: 10.1158/1538-7445.Am2014-976 |
0.482 |
|
| 2014 |
Chen L, Cui B, Zhang S, Mraz M, Fecteau J, Yu J, Zhang L, Bao L, Rassenti L, Messer K, Croce C, Kipps T. Abstract 975: MicroRNA-155 In chronic lymphocytic leukemia influences B-cell receptor signaling Cancer Research. 74: 975-975. DOI: 10.1158/1538-7445.Am2014-975 |
0.474 |
|
| 2014 |
Piovan C, Leva GD, Cheung D, Fassan M, Kumar A, Palmieri D, Iorio MV, Croce CM. Abstract 530: MicroRNA expression profiling in MMTV-neubreast cancer mouse model Cancer Research. 74: 530-530. DOI: 10.1158/1538-7445.Am2014-530 |
0.419 |
|
| 2014 |
Furnari F, Gomez G, Volinia S, Croce C, Zanca C, Li M, Gutmann D, Brennan C, Cavenee W. MUTANT EGFR SUPPRESSION OF MICRORNA-9 INDUCES FOXP1 TO ENHANCE GLIOBLASTOMA TUMORIGENICITY Neuro-Oncology. 16: iii14-iii15. DOI: 10.1093/Neuonc/Nou206.52 |
0.444 |
|
| 2014 |
Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco A. Corrigendum to The high mobility group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression [Mol. Oncol., 7(3), (Jan. 2013), 531-542] Molecular Oncology. 8: 159. DOI: 10.1016/J.Molonc.2013.12.007 |
0.379 |
|
| 2014 |
Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, Tam C, Mackay F. S-15 Cytokine. 70: 24. DOI: 10.1016/J.Cyto.2014.07.235 |
0.31 |
|
| 2013 |
Gaudio E, Paduano F, Spizzo R, Ngankeu A, Zanesi N, Gaspari M, Ortuso F, Lovat F, Rock J, Hill GA, Kaou M, Cuda G, Aqeilan RI, Alcaro S, Croce CM, et al. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel. Plos One. 8: e78610. PMID 24223161 DOI: 10.1371/Journal.Pone.0078610 |
0.313 |
|
| 2013 |
Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CM. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 18208-13. PMID 24145403 DOI: 10.1073/Pnas.1315365110 |
0.428 |
|
| 2013 |
Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, Lehman A, Ruppert AS, Bolon B, Andritsos L, Lozanski A, Rassenti L, Zhao W, Jarvinen TM, Senter L, ... Croce CM, et al. Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. Plos One. 8: e76607. PMID 24130782 DOI: 10.1371/Journal.Pone.0076607 |
0.344 |
|
| 2013 |
Balatti V, Pekarky Y, Rizzotto L, Croce CM. miR deregulation in CLL. Advances in Experimental Medicine and Biology. 792: 309-25. PMID 24014303 DOI: 10.1007/978-1-4614-8051-8_14 |
0.483 |
|
| 2013 |
Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, Liu L, Luo Z, Sun HL, Cui R, Wei H, Kim T, Lee TJ, Jeon YJ, Nuovo GJ, Volinia S, ... ... Croce CM, et al. Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 15043-8. PMID 23980150 DOI: 10.1073/Pnas.1307107110 |
0.599 |
|
| 2013 |
Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5423-33. PMID 23946296 DOI: 10.1158/1078-0432.Ccr-13-0320 |
0.645 |
|
| 2013 |
Balkhi MY, Balkhi MY, Iwenofu OH, Bakkar N, Ladner KJ, Chandler DS, Houghton PJ, London CA, Kraybill W, Perrotti D, Croce CM, Keller C, Guttridge DC. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Science Signaling. 6: ra63. PMID 23901138 DOI: 10.1126/Scisignal.2004177 |
0.43 |
|
| 2013 |
Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM. MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 8: e67581. PMID 23805317 DOI: 10.1371/Journal.Pone.0067581 |
0.752 |
|
| 2013 |
Laganà A, Russo F, Veneziano D, Bella SD, Giugno R, Pulvirenti A, Croce CM, Ferro A. Extracellular circulating viral microRNAs: current knowledge and perspectives. Frontiers in Genetics. 4: 120. PMID 23805153 DOI: 10.3389/Fgene.2013.00120 |
0.394 |
|
| 2013 |
Di Leva G, Croce CM. The Role of microRNAs in the Tumorigenesis of Ovarian Cancer. Frontiers in Oncology. 3: 153. PMID 23785667 DOI: 10.3389/Fonc.2013.00153 |
0.725 |
|
| 2013 |
Garofalo M, Croce CM. MicroRNAs as therapeutic targets in chemoresistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 16: 47-59. PMID 23757365 DOI: 10.1016/J.Drup.2013.05.001 |
0.414 |
|
| 2013 |
Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston M. Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. The Journal of Surgical Research. 184: 855-60. PMID 23726431 DOI: 10.1016/J.Jss.2013.04.061 |
0.45 |
|
| 2013 |
Di Leva G, Croce CM. MicroRNAs. Clinical Biochemistry. 46: 840-1. PMID 23726294 DOI: 10.1016/j.clinbiochem.2013.05.060 |
0.724 |
|
| 2013 |
Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, ... ... Croce CM, et al. Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression. Proceedings of the National Academy of Sciences of the United States of America. 110: 9812-7. PMID 23716670 DOI: 10.1073/Pnas.1304610110 |
0.34 |
|
| 2013 |
Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, ... ... Croce CM, et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 110: 9845-50. PMID 23697367 DOI: 10.1073/Pnas.1305472110 |
0.431 |
|
| 2013 |
Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD, Zaninotto G, Croce CM, Rugge Md Facg M. MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clinical and Translational Gastroenterology. 4: e34. PMID 23677165 DOI: 10.1038/Ctg.2013.5 |
0.343 |
|
| 2013 |
Chen Y, Jacamo R, Konopleva M, Garzon R, Croce C, Andreeff M. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia. The Journal of Clinical Investigation. 123: 2395-407. PMID 23676502 DOI: 10.1172/Jci66553 |
0.356 |
|
| 2013 |
Croce CM. MicroRNA dysregulation in acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2065-6. PMID 23650415 DOI: 10.1200/Jco.2013.48.8239 |
0.429 |
|
| 2013 |
Acunzo M, Romano G, Palmieri D, Laganá A, Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P, Croce CM. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proceedings of the National Academy of Sciences of the United States of America. 110: 8573-8. PMID 23650389 DOI: 10.1073/Pnas.1302107110 |
0.403 |
|
| 2013 |
Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, ... ... Croce CM, et al. Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation. Acs Chemical Biology. 8: 1497-506. PMID 23627474 DOI: 10.1021/Cb3007192 |
0.344 |
|
| 2013 |
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, ... ... Croce CM, et al. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. The Journal of Experimental Medicine. 210: 951-68. PMID 23610125 DOI: 10.1084/Jem.20120950 |
0.468 |
|
| 2013 |
Liu J, Chen G, Feng L, Zhang W, Pelicano H, Wang F, Ogasawara MA, Lu W, Amin HM, Croce CM, Keating MJ, Huang P. Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells. Leukemia. 28: 118-28. PMID 23608884 DOI: 10.1038/Leu.2013.125 |
0.432 |
|
| 2013 |
Zanesi N, Balatti V, Riordan J, Burch A, Rizzotto L, Palamarchuk A, Cascione L, Lagana A, Dupuy AJ, Croce CM, Pekarsky Y. A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model. Blood. 121: 4355-8. PMID 23591791 DOI: 10.1182/Blood-2013-02-486035 |
0.333 |
|
| 2013 |
Volinia S, Croce CM. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 7413-7. PMID 23589849 DOI: 10.1073/Pnas.1304977110 |
0.425 |
|
| 2013 |
Tili E, Michaille JJ, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunological Reviews. 253: 167-84. PMID 23550646 DOI: 10.1111/Imr.12050 |
0.472 |
|
| 2013 |
Chen SS, Batliwalla F, Holodick NE, Yan XJ, Yancopoulos S, Croce CM, Rothstein TL, Chiorazzi N. Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 110: E1500-7. PMID 23550156 DOI: 10.1073/Pnas.1300616110 |
0.332 |
|
| 2013 |
Borbone E, De Rosa M, Siciliano D, Altucci L, Croce CM, Fusco A. Up-regulation of miR-146b and down-regulation of miR-200b contribute to the cytotoxic effect of histone deacetylase inhibitors on ras-transformed thyroid cells. The Journal of Clinical Endocrinology and Metabolism. 98: E1031-40. PMID 23543665 DOI: 10.1210/Jc.2012-4092 |
0.353 |
|
| 2013 |
Manfè V, Biskup E, Willumsgaard A, Skov AG, Palmieri D, Gasparini P, Laganá A, Woetmann A, Ødum N, Croce CM, Gniadecki R. cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas. Plos One. 8: e59390. PMID 23527180 DOI: 10.1371/Journal.Pone.0059390 |
0.438 |
|
| 2013 |
Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, ... ... Croce CM, et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. Plos Genetics. 9: e1003311. PMID 23505378 DOI: 10.1371/Journal.Pgen.1003311 |
0.756 |
|
| 2013 |
Di Leva G, Croce CM. miRNA profiling of cancer. Current Opinion in Genetics & Development. 23: 3-11. PMID 23465882 DOI: 10.1016/J.Gde.2013.01.004 |
0.73 |
|
| 2013 |
Ouzounova M, Vuong T, Ancey PB, Ferrand M, Durand G, Le-Calvez Kelm F, Croce C, Matar C, Herceg Z, Hernandez-Vargas H. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. Bmc Genomics. 14: 139. PMID 23445407 DOI: 10.1186/1471-2164-14-139 |
0.414 |
|
| 2013 |
Trotta R, Chen L, Costinean S, Josyula S, Mundy-Bosse BL, Ciarlariello D, Mao C, Briercheck EL, McConnell KK, Mishra A, Yu L, Croce CM, Caligiuri MA. Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood. 121: 3126-34. PMID 23422749 DOI: 10.1182/Blood-2012-12-467597 |
0.423 |
|
| 2013 |
Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene. 33: 702-12. PMID 23416980 DOI: 10.1038/Onc.2013.13 |
0.615 |
|
| 2013 |
Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Molecular Cancer. 12: 13. PMID 23409773 DOI: 10.1186/1476-4598-12-13 |
0.302 |
|
| 2013 |
Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K. Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. Plos One. 8: e55910. PMID 23405235 DOI: 10.1371/Journal.Pone.0055910 |
0.437 |
|
| 2013 |
Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco A. The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression. Molecular Oncology. 7: 531-42. PMID 23384558 DOI: 10.1016/J.Molonc.2013.01.002 |
0.45 |
|
| 2013 |
Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors Rna Biology. 10: 169-174. PMID 23296026 DOI: 10.4161/Rna.23144 |
0.414 |
|
| 2013 |
Nana‐Sinkam SP, Croce CM. Clinical Applications for microRNAs in Cancer Clinical Pharmacology & Therapeutics. 93: 98-104. PMID 23212103 DOI: 10.1038/Clpt.2012.192 |
0.431 |
|
| 2013 |
Gaudio E, Paduano F, Ngankeu A, Lovat F, Fabbri M, Sun HL, Gasparini P, Efanov A, Peng Y, Zanesi N, Shuaib MA, Rassenti LZ, Kipps TJ, Li C, Aqeilan RI, ... ... Croce CM, et al. Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas. Blood. 121: 351-9. PMID 23160471 DOI: 10.1182/Blood-2012-09-457374 |
0.308 |
|
| 2013 |
Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs S. MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer. Oncogene. 32: 4139-47. PMID 22986525 DOI: 10.1038/Onc.2012.424 |
0.452 |
|
| 2013 |
Tsongalis GJ, Calin GA, Cordelier P, Croce C, Monzon F, Szafranska-Schwarzbach AE. MicroRNA Analysis: Is It Ready for Prime Time? Clinical Chemistry. 59: 343-347. PMID 22935643 DOI: 10.1373/Clinchem.2012.185009 |
0.423 |
|
| 2013 |
Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, ... ... Croce CM, et al. Correction: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status Plos Genetics. 9. DOI: 10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46 |
0.693 |
|
| 2013 |
Lautenschlaeger T, Meng W, Ye Z, Cui R, Perry J, Huebner A, Dedousi-Huebner V, Stefano V, Hiroshi N, Kim T, Suh S, Ayers LW, Ross P, Croce CM, Jin V, et al. Lung adenocarcinoma microRNA-31 expression levels to predict lymph node metastasis and patient survival. Journal of Clinical Oncology. 31: 7573-7573. DOI: 10.1200/Jco.2013.31.15_Suppl.7573 |
0.621 |
|
| 2013 |
Landi L, Gasparini P, Carasi S, Tibaldi C, Cascione L, Ali' G, D'Incecco A, Salvini J, Minuti G, Chella A, Fontanini G, Cappuzzo F, Croce CM. Micro-RNA signature differences in lung adenocarcinoma with specific driver alterations. Journal of Clinical Oncology. 31: 11066-11066. DOI: 10.1200/Jco.2013.31.15_Suppl.11066 |
0.412 |
|
| 2013 |
Veronese A, Pepe F, Chiacchia J, Pagotto S, Veschi S, Di marco M, D'Argenio A, Russo M, Vannata B, Innocenti I, Leone G, Autore F, Wernicke-Jameson D, Verginelli F, Rassenti L, ... ... Croce CM, et al. Allele-Specific Loss Of The Mir-15a/16-1 Cluster Correlates With ZAP70 Expression In CLL Patients With 13q Deletion Blood. 122: 3753-3753. DOI: 10.1182/Blood.V122.21.3753.3753 |
0.42 |
|
| 2013 |
Andreeff M, Wang R, Davis RE, Jacamo R, Ruvolo PP, McQueen T, Huang X, Battula VL, Chen Y, Majumdar S, Benito JM, Zeng Z, Benton CB, Carter BZ, Mu H, ... ... Croce CM, et al. Proteomic, Gene Expression, and Micro-RNA Analysis Of Bone Marrow Mesenchymal Stromal Cells In Acute Myeloid Leukemia Identifies Pro-Inflammatory, Pro-Survival Signatures In Vitro and In Vivo Blood. 122: 3685-3685. DOI: 10.1182/Blood.V122.21.3685.3685 |
0.404 |
|
| 2013 |
Vasquez ML, Volinia S, Fernandez C, Zanesi N, Fazio G, Zalcberg IR, Garzon R, Cazzaniga G, Biondi A, Croce CM. Multivariate Analysis Reveals a miRNA Profile Correlated To Karyotype and Outcome In Pediatric B-Cell Precursor ALL Blood. 122: 2597-2597. DOI: 10.1182/Blood.V122.21.2597.2597 |
0.443 |
|
| 2013 |
Ruvolo PP, Wang R, Ruvolo VR, Jacamo R, McQueen T, Borthakur G, Qiu Y, Coombes KR, Zhang N, Shpall EJ, Champlin RE, Garzon R, Marcucci G, Croce CM, Konopleva M, et al. Phosphorylation Of GSK3β Is Associated With Inferior Survival In Acute Myeloid Leukemia and Is An Indicator Of AKT Activation In AML Blasts and Bone Marrow Mesenchymal Stem Cells Blood. 122: 2551-2551. DOI: 10.1182/Blood.V122.21.2551.2551 |
0.36 |
|
| 2013 |
Di Leva G, Croce CM. miRNAs in Cancer Initiation and Progression Aacr Education Book. 2013: 57-62. DOI: 10.1158/Aacr.Edb-13-8024 |
0.378 |
|
| 2013 |
Leva GD, Piovan C, Cheung D, Briskin D, Kumar A, Nuovo G, Fassan M, Coppola V, Garofalo M, Croce C. Abstract A085: miR-222/221 in aggressive breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A085 |
0.505 |
|
| 2013 |
Jeon Y, Nuovo GJ, Midddleton J, Joshi P, Nazaryan N, Leva GD, Romano G, Crawford M, Nana-Sinkam P, Garofalo M, Croce CM. Abstract LB-244: MiR-34a/c-dependent PDGFR-α/β reduction inhibits tumorigenesis and sensitizes TRAIL-induced apoptosis in lung cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-244 |
0.488 |
|
| 2013 |
Taccioli C, Chen H, Garofalo M, Jiang Y, Leva GD, Alder H, Middleton J, Smalley KJ, Bottoni A, Costinean S, Farber JL, Croce CM, Fong LYY. Abstract LB-241: Silencing of microRNA-31 prevents esophageal neoplasia in zinc deficient rats. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-241 |
0.443 |
|
| 2013 |
Acunzo M, Nuovo JG, Zanesi N, Leva GD, Pichiorri F, Volinia S, Fernandez C, Costinenan S, Bottoni A, Burch A, Alder H, Conti L, Antenucci A, Rosito IA, Ciardi A, ... ... Croce CM, et al. Abstract 5326: MicroRNA profiles discriminate among colon cancer metastasis. Cancer Research. 73: 5326-5326. DOI: 10.1158/1538-7445.Am2013-5326 |
0.442 |
|
| 2013 |
Ruvolo PP, Ruvolo V, Jacamo R, Qiu Y, Coombes K, Zhang N, Garzon R, Kornblau SM, Croce C, Andreeff M. Abstract 4120: Low expression of PP2A/B55α is associated with increased MiR-191 expression and relapse in acute myeloid leukemia. Cancer Research. 73: 4120-4120. DOI: 10.1158/1538-7445.Am2013-4120 |
0.463 |
|
| 2013 |
Gasparini P, Landi L, Carasi S, Tibaldi C, Cascione L, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Cappuzzo F, Croce CM. Abstract 3061: Micro-RNA signature differences in lung cancer patients withALKtranslocation,EGFRmutations andKRASmutations. Cancer Research. 73: 3061-3061. DOI: 10.1158/1538-7445.Am2013-3061 |
0.433 |
|
| 2013 |
Sapienza MR, Fuligni F, Laginestra MA, Rossi M, Cascione L, Laganà A, Agostinelli C, Etebari M, Gazzola A, Mannu C, Sabattini E, Bacci F, Croce CM, Pileri SA, Piccaluga PP. Abstract 1951: miRNA expression profile of Blastic plasmacytoid dendritic cell neoplasm. Cancer Research. 73: 1951-1951. DOI: 10.1158/1538-7445.Am2013-1951 |
0.427 |
|
| 2013 |
Joshi P, Garofalo M, Croce CM. Abstract 1943: miR-148a overexpression reduces TRAIL resistance and tumorigenesis in NSCLC. Cancer Research. 73: 1943-1943. DOI: 10.1158/1538-7445.Am2013-1943 |
0.51 |
|
| 2013 |
Kim T, Croce CM. Abstract 1830: Cancer-associated variants at 8q24 are correlated with expression of adjacent long non-coding RNAs involved in cell cycle regulation. Cancer Research. 73: 1830-1830. DOI: 10.1158/1538-7445.Am2013-1830 |
0.502 |
|
| 2013 |
Palmieri D, Luca LD, Consiglio J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Coppola V, Hofmeister C, Marcucci G, Byrd J, ... ... Croce C, et al. Abstract 1122: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation. Cancer Research. 73: 1122-1122. DOI: 10.1158/1538-7445.Am2013-1122 |
0.485 |
|
| 2013 |
Balkhi MY, Iwenofu OH, Bakkar N, Ladner KJ, Chandler DS, Houghton PJ, London CA, Kraybill W, Perrotti D, Croce CM, Keller C, Guttridge DC. Erratum: miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR (Science Signaling (2013) 6 (er6)) Science Signaling. 6. DOI: 10.1126/Scisignal.292Er6 |
0.371 |
|
| 2013 |
Braconi C, Valeri N, Gasparini P, Jiang J, Kogure T, Croce C, Schmittgen T, Patel T. Transcribed ultraconserved regions are aberrantly expressed and can be modulated by interleukin 6 in cholangiocarcinoma The Lancet. 381. DOI: 10.1016/S0140-6736(13)60466-3 |
0.387 |
|
| 2012 |
Valeri N, Braconi C, Gasparini P, Grivennikow S, Hart JR, Paone A, Lovat F, Fabbri M, Gafa' R, Nuovo G, Lanza G, Frankel W, Vogt PK, Groden J, Karin M, ... Croce CM, et al. Anti-miR-135b in colon cancer treatment: Results from a preclinical study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 457. PMID 27983220 DOI: 10.1200/Jco.2012.30.4_Suppl.457 |
0.431 |
|
| 2012 |
Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G, Garzon R, Croce CM. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America. 109: 20047-52. PMID 23169640 DOI: 10.1073/Pnas.1213764109 |
0.464 |
|
| 2012 |
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. The Journal of Biological Chemistry. 287: 42084-92. PMID 23060446 DOI: 10.1074/Jbc.M112.377515 |
0.444 |
|
| 2012 |
Laganà A, Paone A, Veneziano D, Cascione L, Gasparini P, Carasi S, Russo F, Nigita G, Macca V, Giugno R, Pulvirenti A, Shasha D, Ferro A, Croce CM. miR-EdiTar: a database of predicted A-to-I edited miRNA target sites. Bioinformatics (Oxford, England). 28: 3166-8. PMID 23044546 DOI: 10.1093/Bioinformatics/Bts589 |
0.331 |
|
| 2012 |
Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C, Bolon B, Condorelli G, Croce CM. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proceedings of the National Academy of Sciences of the United States of America. 109: 16570-5. PMID 23012423 DOI: 10.1073/Pnas.1207917109 |
0.766 |
|
| 2012 |
Colamaio M, Calì G, Sarnataro D, Borbone E, Pallante P, Decaussin-Petrucci M, Nitsch L, Croce CM, Battista S, Fusco A. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene. The Journal of Clinical Endocrinology and Metabolism. 97: E2168-78. PMID 22965940 DOI: 10.1210/Jc.2012-1929 |
0.409 |
|
| 2012 |
Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli G. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene. 32: 4001-8. PMID 22964638 DOI: 10.1038/Onc.2012.410 |
0.442 |
|
| 2012 |
Smith KM, Guerau-de-Arellano M, Costinean S, Williams JL, Bottoni A, Mavrikis Cox G, Satoskar AR, Croce CM, Racke MK, Lovett-Racke AE, Whitacre CC. miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 189: 1567-76. PMID 22772450 DOI: 10.4049/Jimmunol.1103171 |
0.43 |
|
| 2012 |
Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, ... ... Croce CM, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences of the United States of America. 109: E2110-6. PMID 22753494 DOI: 10.1073/Pnas.1209414109 |
0.453 |
|
| 2012 |
Leone V, D'Angelo D, Pallante P, Croce CM, Fusco A. Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3. The Journal of Clinical Endocrinology and Metabolism. 97: 3292-301. PMID 22730517 DOI: 10.1210/Jc.2012-1349 |
0.467 |
|
| 2012 |
Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CM. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood. 120: 2631-8. PMID 22723551 DOI: 10.1182/Blood-2012-03-415737 |
0.416 |
|
| 2012 |
Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu CC. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood. 120: 1027-38. PMID 22692508 DOI: 10.1182/Blood-2011-11-394346 |
0.346 |
|
| 2012 |
Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LY. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis. 33: 1736-44. PMID 22689922 DOI: 10.1093/Carcin/Bgs204 |
0.447 |
|
| 2012 |
Ranganathan P, Yu X, Na C, Santhanam R, Shacham S, Kauffman M, Walker A, Klisovic R, Blum W, Caligiuri M, Croce CM, Marcucci G, Garzon R. Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood. 120: 1765-73. PMID 22677130 DOI: 10.1182/Blood-2012-04-423160 |
0.353 |
|
| 2012 |
Iorio MV, Croce CM. Causes and consequences of microRNA dysregulation. Cancer Journal (Sudbury, Mass.). 18: 215-22. PMID 22647357 DOI: 10.1097/Ppo.0B013E318250C001 |
0.439 |
|
| 2012 |
Croce C. Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment. Cancer Journal (Sudbury, Mass.). 18: 213-4. PMID 22647356 DOI: 10.1097/Ppo.0B013E31825Efb41 |
0.333 |
|
| 2012 |
Ryan BM, McClary AC, Valeri N, Robinson D, Paone A, Bowman ED, Robles AI, Croce C, Harris CC. rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. Plos One. 7: e36306. PMID 22606253 DOI: 10.1371/Journal.Pone.0036306 |
0.385 |
|
| 2012 |
Zanesi N, Balatti V, Bottoni A, Croce CM, Pekarsky Y. Novel insights in molecular mechanisms of CLL. Current Pharmaceutical Design. 18: 3363-72. PMID 22591386 DOI: 10.2174/138161212801227104 |
0.384 |
|
| 2012 |
Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CM. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Molecular Oncology. 6: 458-72. PMID 22578566 DOI: 10.1016/J.Molonc.2012.03.003 |
0.763 |
|
| 2012 |
Wang H, Chiu M, Xie Z, Chiu M, Liu Z, Chen P, Liu S, Byrd JC, Muthusamy N, Garzon R, Croce CM, Marcucci G, Chan KK. Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Molecular Pharmaceutics. 9: 1638-44. PMID 22574727 DOI: 10.1021/Mp2006483 |
0.406 |
|
| 2012 |
D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. The Journal of Clinical Endocrinology and Metabolism. 97: E1128-38. PMID 22564666 DOI: 10.1210/Jc.2011-3482 |
0.405 |
|
| 2012 |
Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Vecchio LD, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, et al. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation Journal of Biological Chemistry. 287: 18308-18317. PMID 22493480 DOI: 10.1074/Jbc.M112.346270 |
0.359 |
|
| 2012 |
Iorio MV, Croce CM. microRNA involvement in human cancer Carcinogenesis. 33: 1126-1133. PMID 22491715 DOI: 10.1093/Carcin/Bgs140 |
0.452 |
|
| 2012 |
Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corrà F, Miotto E, Lupini L, Bolondi L, ... ... Croce CM, et al. Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology (Baltimore, Md.). 56: 1025-33. PMID 22473819 DOI: 10.1002/Hep.25747 |
0.46 |
|
| 2012 |
Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury Journal of Cellular and Molecular Medicine. 16: 2647-2654. PMID 22469499 DOI: 10.1111/J.1582-4934.2012.01578.X |
0.432 |
|
| 2012 |
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakà cs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 109: 5316-21. PMID 22431589 DOI: 10.1073/Pnas.1202465109 |
0.727 |
|
| 2012 |
Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, Santhanam R, Mao C, Taylor PA, Sandhu S, He G, Shana'ah A, Nuovo GJ, Lagana A, Cascione L, ... ... Croce CM, et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood. 119: 4786-97. PMID 22408260 DOI: 10.1182/Blood-2011-10-387522 |
0.42 |
|
| 2012 |
Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Yu L, Butchar JP, Tridandapani S, Croce CM, Caligiuri MA. miR-155 regulates IFN-γ production in natural killer cells. Blood. 119: 3478-85. PMID 22378844 DOI: 10.1182/Blood-2011-12-398099 |
0.385 |
|
| 2012 |
Iorio MV, Croce CM. MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review Embo Molecular Medicine. 4: 143-159. PMID 22351564 DOI: 10.1002/Emmm.201100209 |
0.413 |
|
| 2012 |
Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, Lian JB, Aqeilan RI. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Research. 72: 1865-77. PMID 22350417 DOI: 10.1158/0008-5472.Can-11-2663 |
0.446 |
|
| 2012 |
Visone R, Veronese A, Balatti V, Croce CM. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. Oncotarget. 3: 195-202. PMID 22350310 DOI: 10.18632/Oncotarget.448 |
0.425 |
|
| 2012 |
Di Leva G, Briskin D, Croce CM. MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Upsala Journal of Medical Sciences. 117: 202-16. PMID 22348396 DOI: 10.3109/03009734.2012.660551 |
0.729 |
|
| 2012 |
Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C, Lu W, Burger JA, Croce CM, Plunkett W, Keating MJ, Huang P. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nature Cell Biology. 14: 276-86. PMID 22344033 DOI: 10.1038/Ncb2432 |
0.313 |
|
| 2012 |
Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proceedings of the National Academy of Sciences of the United States of America. 109: 3024-9. PMID 22315424 DOI: 10.1073/Pnas.1200010109 |
0.385 |
|
| 2012 |
Palamarchuk A, Yan PS, Zanesi N, Wang L, Rodrigues B, Murphy M, Balatti V, Bottoni A, Nazaryan N, Alder H, Rassenti L, Kipps TJ, Freitas M, Croce CM, Pekarsky Y. Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proceedings of the National Academy of Sciences of the United States of America. 109: 2555-60. PMID 22308499 DOI: 10.1073/Pnas.1200003109 |
0.328 |
|
| 2012 |
Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. The Journal of Pathology. 227: 275-85. PMID 22262409 DOI: 10.1002/Path.3995 |
0.424 |
|
| 2012 |
Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM, Ambs S. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Research. 40: 3689-703. PMID 22210864 DOI: 10.1093/nar/gkr1222 |
0.349 |
|
| 2012 |
Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LY. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene. 31: 4550-8. PMID 22179833 DOI: 10.1038/Onc.2011.592 |
0.324 |
|
| 2012 |
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, ... ... Croce CM, et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine. 18: 74-82. PMID 22157681 DOI: 10.1038/Nm.2577 |
0.756 |
|
| 2012 |
Garofalo M, Quintavalle C, Romano G, Croce CM, Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Current Molecular Medicine. 12: 27-33. PMID 22082479 DOI: 10.2174/156652412798376170 |
0.493 |
|
| 2012 |
Mathé E, Nguyen GH, Funamizu N, He P, Moake M, Croce CM, Hussain SP. Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. International Journal of Cancer. Journal International Du Cancer. 131: 760-5. PMID 22042537 DOI: 10.1002/Ijc.26403 |
0.437 |
|
| 2012 |
Sozzi G, Pastorino U, Croce CM. MicroRNAs and lung cancer: from markers to targets. Cell Cycle (Georgetown, Tex.). 10: 2045-6. PMID 21623159 DOI: 10.4161/Cc.10.13.15712 |
0.342 |
|
| 2012 |
Ruvolo PP, Jacamo R, Ruvolo VR, Burks JK, Battula VL, McQueen T, Konopleva M, Kornblau SM, Garzon R, Croce CM, Andreeff M. Exosomes Mediate Communication Between the Microenvironment and Leukemic Cells in Acute Myeloid Leukemia Blood. 120: 3469-3469. DOI: 10.1182/Blood.V120.21.3469.3469 |
0.422 |
|
| 2012 |
Stiff A, Rocci A, Hofmeister CC, Omedè P, Geyer S, Bringhen S, Cascione L, Bingman A, Gambella M, Cavallo F, De Luca L, Guan J, Larocca A, Corry J, Gay F, ... ... Croce CM, et al. miRNA in Serum and Bone Marrow Plasma Cells From Multiple Myeloma Patients. Blood. 120: 2921-2921. DOI: 10.1182/Blood.V120.21.2921.2921 |
0.439 |
|
| 2012 |
Ruvolo PP, Jacamo R, McQueen T, Pan R, Samudio I, Konopleva M, Kornblau SM, Garzon R, Croce CM, Andreeff M. Suppression of Mir-93 May Regulate Anti-Oxidant Metabolism in Mesenchymal Stromal Cells Derived From Acute Myeloid Leukemia Patients. Blood. 120: 2354-2354. DOI: 10.1182/Blood.V120.21.2354.2354 |
0.431 |
|
| 2012 |
Beckwith KA, Frissora FW, Stefanovski MR, Deckert J, Croce CM, Mo X, Jarjoura D, Byrd JC, Muthusamy N. A Transgenic Mouse Model of Aggressive B-Cell Malignancy for Evaluating Anti-Human CD37 Therapeutics Blood. 120: 188-188. DOI: 10.1182/Blood.V120.21.188.188 |
0.308 |
|
| 2012 |
Bennardo S, Iacovelli S, Gobessi S, Suljagic M, Bilbao D, Eckl-Dorna J, Wang H, Cornall RJ, Clarke SH, Croce CM, Efremov DG. The Nature of the Antigen Determines Leukemia Development and Behavior in the Eμ-TCL1 Transgenic Mouse Model of CLL Blood. 120: 181-181. DOI: 10.1182/Blood.V120.21.181.181 |
0.335 |
|
| 2012 |
Consiglio J, Vecchione A, Galasso M, Rocci A, Acunzo M, Sapienza MR, Volinia S, Piccaluga PP, De R, Talabere T, Guan J, Zanesi N, Croce CM, Pichiorri F. MiR-221 and MiR-222 Patterns Characterize Burkitt Lymphoma in Human and Mouse Model Blood. 120: 1304-1304. DOI: 10.1182/Blood.V120.21.1304.1304 |
0.496 |
|
| 2012 |
Croce CM. Abstract ED06-02: MicroRNAs and cancer progression Cancer Prevention Research. 5: ED06-02-ED06-02. DOI: 10.1158/1940-6207.Prev-12-Ed06-02 |
0.449 |
|
| 2012 |
Hudson RS, Dorsey TH, Yi M, Esposito D, Stephens RM, Croce CM, Ambs S. Abstract C23: MicroRNA-106b targets caspase-7 and is associated with recurrence in human prostate cancer Cancer Research. 72: C23-C23. DOI: 10.1158/1538-7445.Prca2012-C23 |
0.427 |
|
| 2012 |
Valeri N, Gafa' R, Nuovo G, Lanza G, Frankel W, Vogt PK, Groden J, Karin M, Croce CM, Braconi C, Gasparini P, Grivennikov S, Hart JR, Paone A, Lovat F, et al. Abstract B14: Anti-miR-135b in colon cancer treatment Cancer Research. 72: B14-B14. DOI: 10.1158/1538-7445.Nonrna12-B14 |
0.339 |
|
| 2012 |
Kim T, Lee TJ, Jeon Y, Pineau P, Dejean A, Croce CM. Abstract A18: p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 Cancer Research. 72: A18-A18. DOI: 10.1158/1538-7445.Nonrna12-A18 |
0.563 |
|
| 2012 |
Liu J, Chen G, Feng L, Zhang W, Pelicano H, Lu W, Amin H, Keating M, Croce CM, Huang P. Abstract LB-106: A novel TCL1-Tg:p53−/− mouse model of human CLL Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-106 |
0.337 |
|
| 2012 |
Consiglio J, Luca LD, Acunzo M, Galasso M, Rocci A, Sapienza M, Piccaluga PP, Vecchione A, Zanesi N, Volinia S, Croce CM, Pichiorri F. Abstract 5032: New insights of miR-221 and miR-222 cluster functions in Burkitt lymphoma. Cancer Research. 72: 5032-5032. DOI: 10.1158/1538-7445.Am2012-5032 |
0.519 |
|
| 2012 |
Zappasodi R, Cavane A, Iorio MV, Tortoreto M, Ruggiero G, Magni M, Tagliabue E, Zunino F, Croce CM, Gianni AM, Nicola MD. Abstract 4719: The HDAC inhibitor ITF2357 blocks c-Myc expression via microRNA modulation and cap-dependent translation inhibition in human Burkitt's lymphoma Cancer Research. 72: 4719-4719. DOI: 10.1158/1538-7445.Am2012-4719 |
0.381 |
|
| 2012 |
Sandhu SK, Neinast R, Balatti V, Lovat F, Volinia S, Pekarsky Y, Croce CM. Abstract 2947: B-cell lymphoma in eα-miR-17∼92 transgenic mice Cancer Research. 72: 2947-2947. DOI: 10.1158/1538-7445.Am2012-2947 |
0.499 |
|
| 2012 |
Motiwala T, Zanesi N, Roy S, Mustafa M, Kutay H, You J, Frissora F, Lu Y, Muthusamy N, Freitas M, Croce CM, Jacob ST. Abstract 1351: Analysis of the in vivo tumor suppressive potential of PTPROt (truncated protein tyrosine phosphatase receptor-type O) in CLL using a transgenic mouse model Cancer Research. 72: 1351-1351. DOI: 10.1158/1538-7445.Am2012-1351 |
0.346 |
|
| 2012 |
Sozzi G, Boeri M, Verri C, Roz L, Suatoni P, Croce CM, Pastorino U. Abstract IA22: miRNA and lung cancer: Early detection in high-risk subjects Clinical Cancer Research. 18: IA22-IA22. DOI: 10.1158/1078-0432.12Aacriaslc-Ia22 |
0.349 |
|
| 2011 |
Braconi C, Kogure T, Valeri N, Gasparini P, Huang N, Nuovo G, Terracciano L, Croce CM, Patel T. Effect of the ultraconserved noncoding RNA uc.338 on cellular growth of hepatocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 202. PMID 27985881 DOI: 10.1200/Jco.2011.29.4_Suppl.202 |
0.326 |
|
| 2011 |
Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract World Journal of Gastroenterology. 17: 5231-5239. PMID 22219591 DOI: 10.3748/Wjg.V17.I48.5231 |
0.387 |
|
| 2011 |
Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Seminars in Oncology. 38: 724-33. PMID 22082758 DOI: 10.1053/J.Seminoncol.2011.08.006 |
0.456 |
|
| 2011 |
Garzon R, Croce CM. MicroRNAs and cancer: Introduction Seminars in Oncology. 38: 721-723. PMID 22082757 DOI: 10.1053/J.Seminoncol.2011.08.008 |
0.368 |
|
| 2011 |
Nana-Sinkam SP, Croce CM. Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Molecular Oncology. 5: 483-91. PMID 22079056 DOI: 10.1016/J.Molonc.2011.10.003 |
0.412 |
|
| 2011 |
Gaudio E, Spizzo R, Paduano F, Luo Z, Efanov A, Palamarchuk A, Leber AS, Kaou M, Zanesi N, Bottoni A, Costinean S, Rassenti LZ, Nakamura T, Kipps TJ, Aqeilan RI, ... ... Croce CM, et al. Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. Blood. 119: 180-7. PMID 22065599 DOI: 10.1182/Blood-2011-08-374561 |
0.346 |
|
| 2011 |
Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TD. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Research. 71: 7608-16. PMID 22009537 DOI: 10.1158/0008-5472.Can-11-1144 |
0.4 |
|
| 2011 |
Motiwala T, Zanesi N, Datta J, Roy S, Kutay H, Checovich AM, Kaou M, Zhong Y, Johnson AJ, Lucas DM, Heerema NA, Hagan J, Mo X, Jarjoura D, Byrd JC, ... Croce CM, et al. AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia. Blood. 118: 6132-40. PMID 22001392 DOI: 10.1182/Blood-2011-01-323147 |
0.349 |
|
| 2011 |
Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S, Agnese DM, Croce CM, Carson WE. MiR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions British Journal of Cancer. 105: 1023-1029. PMID 21863027 DOI: 10.1038/Bjc.2011.288 |
0.392 |
|
| 2011 |
Croce CM. MiRNAs in the spotlight: Understanding cancer gene dependency Nature Medicine. 17: 935-936. PMID 21818092 DOI: 10.1038/Nm0811-935 |
0.39 |
|
| 2011 |
Leone V, D'Angelo D, Ferraro A, Pallante P, Rubio I, Santoro M, Croce CM, Fusco A. A TSH-CREB1-microRNA loop is required for thyroid cell growth. Molecular Endocrinology (Baltimore, Md.). 25: 1819-30. PMID 21816899 DOI: 10.1210/Me.2011-0014 |
0.461 |
|
| 2011 |
Quintavalle C, Garofalo M, Croce CM, Condorelli G. "ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. Vascular Pharmacology. 55: 87-91. PMID 21798370 DOI: 10.1016/J.Vph.2011.07.004 |
0.389 |
|
| 2011 |
Basu A, Alder H, Khiyami A, Leahy P, Croce CM, Haldar S. MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer. Genes & Cancer. 2: 108-19. PMID 21779484 DOI: 10.1177/1947601911409212 |
0.408 |
|
| 2011 |
Quintavalle C, Garofalo M, Zanca C, Romano G, Iaboni M, del Basso De Caro M, Martinez-Montero JC, Incoronato M, Nuovo G, Croce CM, Condorelli G. miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene. 31: 858-68. PMID 21743492 DOI: 10.1038/Onc.2011.280 |
0.445 |
|
| 2011 |
Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G, Chiariello M, Croce CM. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene. 31: 634-42. PMID 21706050 DOI: 10.1038/Onc.2011.260 |
0.433 |
|
| 2011 |
Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M, Volinia S, Taccioli C, Kipps TJ, Croce CM. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 118: 3072-9. PMID 21636858 DOI: 10.1182/Blood-2011-01-333484 |
0.4 |
|
| 2011 |
Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, Lunardi M, Munerato G, Querzoli G, Maestri I, Ulazzi L, Nenci I, Croce CM, Lanza G, Querzoli P, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. The Journal of Pathology. 225: 43-53. PMID 21630269 DOI: 10.1002/Path.2915 |
0.347 |
|
| 2011 |
Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ, Stein GS. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proceedings of the National Academy of Sciences of the United States of America. 108: 9863-8. PMID 21628588 DOI: 10.1073/Pnas.1018493108 |
0.453 |
|
| 2011 |
Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM, Patel T. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 30: 4750-6. PMID 21625215 DOI: 10.1038/Onc.2011.193 |
0.442 |
|
| 2011 |
Negrini M, Gramantieri L, Sabbioni S, Croce CM. microRNA involvement in hepatocellular carcinoma. Anti-Cancer Agents in Medicinal Chemistry. 11: 500-21. PMID 21554203 DOI: 10.2174/187152011796011037 |
0.395 |
|
| 2011 |
Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease Current Opinion in Hematology. 18: 266-272. PMID 21519241 DOI: 10.1097/Moh.0B013E3283476012 |
0.403 |
|
| 2011 |
Orlovsky K, Kalinkovich A, Rozovskaia T, Shezen E, Itkin T, Alder H, Ozer HG, Carramusa L, Avigdor A, Volinia S, Buchberg A, Mazo A, Kollet O, Largman C, Croce CM, et al. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Proceedings of the National Academy of Sciences of the United States of America. 108: 7956-61. PMID 21518888 DOI: 10.1073/Pnas.1103154108 |
0.352 |
|
| 2011 |
Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. The Journal of Experimental Medicine. 208: 875-83. PMID 21518799 DOI: 10.1084/Jem.20110235 |
0.706 |
|
| 2011 |
Abdeen SK, Salah Z, Maly B, Smith Y, Tufail R, Abu-Odeh M, Zanesi N, Croce CM, Nawaz Z, Aqeilan RI. Wwox inactivation enhances mammary tumorigenesis. Oncogene. 30: 3900-6. PMID 21499303 DOI: 10.1038/Onc.2011.115 |
0.333 |
|
| 2011 |
Sandhu SK, Croce CM, Garzon R. Micro-RNA Expression and Function in Lymphomas. Advances in Hematology. 2011: 347137. PMID 21461378 DOI: 10.1155/2011/347137 |
0.38 |
|
| 2011 |
Havelange V, Stauffer N, Heaphy CC, Volinia S, Andreeff M, Marcucci G, Croce CM, Garzon R. Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer. 117: 4696-706. PMID 21455993 DOI: 10.1002/Cncr.26096 |
0.381 |
|
| 2011 |
Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Translational Research : the Journal of Laboratory and Clinical Medicine. 157: 216-25. PMID 21420032 DOI: 10.1016/J.Trsl.2011.01.013 |
0.425 |
|
| 2011 |
Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 4908-13. PMID 21383199 DOI: 10.1073/pnas.1101795108 |
0.319 |
|
| 2011 |
Veronese A, Visone R, Consiglio J, Acunzo M, Lupini L, Kim T, Ferracin M, Lovat F, Miotto E, Balatti V, D'Abundo L, Gramantieri L, Bolondi L, Pekarsky Y, Perrotti D, ... ... Croce CM, et al. Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proceedings of the National Academy of Sciences of the United States of America. 108: 4840-5. PMID 21383185 DOI: 10.1073/Pnas.1101734108 |
0.548 |
|
| 2011 |
Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, ... ... Croce CM, et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proceedings of the National Academy of Sciences of the United States of America. 108: 4394-9. PMID 21368194 DOI: 10.1073/Pnas.1014720108 |
0.429 |
|
| 2011 |
Palmieri D, Valentino T, D'Angelo D, De Martino I, Postiglione I, Pacelli R, Croce CM, Fedele M, Fusco A. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene. 30: 3024-35. PMID 21339738 DOI: 10.1038/Onc.2011.21 |
0.357 |
|
| 2011 |
Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. British Journal of Haematology. 153: 24-32. PMID 21332710 DOI: 10.1111/J.1365-2141.2011.08581.X |
0.397 |
|
| 2011 |
Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene. 30: 2767-77. PMID 21317924 DOI: 10.1038/Onc.2010.643 |
0.478 |
|
| 2011 |
Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, Croce CM, Pastorino U, Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 3713-8. PMID 21300873 DOI: 10.1073/Pnas.1100048108 |
0.346 |
|
| 2011 |
Fong LY, Jiang Y, Rawahneh ML, Smalley KJ, Croce CM, Farber JL, Huebner K. Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. Carcinogenesis. 32: 554-60. PMID 21245412 DOI: 10.1093/Carcin/Bgr004 |
0.303 |
|
| 2011 |
Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, ... ... Croce CM, et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Jama. 305: 59-67. PMID 21205967 DOI: 10.1001/Jama.2010.1919 |
0.32 |
|
| 2011 |
Nana-Sinkam SP, Croce CM. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. Cancer Genetics and Cytogenetics. 203: 127-33. PMID 21156224 DOI: 10.1016/J.Cancergencyto.2010.09.007 |
0.449 |
|
| 2011 |
Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, Battaglia G, Parente P, Croce CM, Zaninotto G, Ancona E, Rugge M. MicroRNA expression profiling in human Barrett's carcinogenesis International Journal of Cancer. 129: 1661-1670. PMID 21128279 DOI: 10.1002/Ijc.25823 |
0.407 |
|
| 2011 |
Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 30: 1082-97. PMID 21057537 DOI: 10.1038/Onc.2010.487 |
0.454 |
|
| 2011 |
Garofalo M, Croce CM. MicroRNAs: Master regulators as potential therapeutics in cancer Annual Review of Pharmacology and Toxicology. 51: 25-43. PMID 20809797 DOI: 10.1146/Annurev-Pharmtox-010510-100517 |
0.429 |
|
| 2011 |
Volinia S, Galasso M, Croce CM, Previati M, Sana ME. Non coding RNAs: reprogramming of miRNAs network in cancer and highly specific transcribed ultraconserved regions in human normal tissues and pluripotent stem cells Italian Journal of Anatomy and Embryology. 116: 199-199. DOI: 10.1400/182961 |
0.451 |
|
| 2011 |
Valeri N, Gasparini P, Braconi C, Lovat F, Paone A, Fabbri M, Nuovo G, Fishel R, Croce CM. Effect of miR-21 on resistance to 5-fluorouracil and regulation of MSH2. Journal of Clinical Oncology. 29: 431-431. DOI: 10.1200/Jco.2011.29.4_Suppl.431 |
0.445 |
|
| 2011 |
Vasquez ML, Zanesi N, Volinia S, Garzon R, Cazzaniga G, Croce CM, Biondi A. MiR-125b Cooperates with BCR-ABL and Enhances Therapy Resistance in Childhood Ph+ ALL Blood. 118: 78-78. DOI: 10.1182/Blood.V118.21.78.78 |
0.435 |
|
| 2011 |
Chen L, Cui B, Chen G, Salcedo M, Croce CM, Kipps TJ. Mir-155 Contributed to Chronic Lymphocytic Leukemia Survival by Modulation of BCR-Signalling Blood. 118: 620-620. DOI: 10.1182/Blood.V118.21.620.620 |
0.442 |
|
| 2011 |
Ghia EM, Werner L, James DF, Neuberg D, Corral LG, Rassenti LZ, Croce CM, Kipps TJ. Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4, Blood. 118: 3885-3885. DOI: 10.1182/Blood.V118.21.3885.3885 |
0.428 |
|
| 2011 |
Rassenti LZ, Ghia EM, Werner L, Neuberg D, Fabbri M, Volinia S, Widhopf GF, Croce CM, Kipps TJ. MicroRNA Profiling in Patients with CLL B Cells Expressing the Unmutated IGHV1-69 Gene Blood. 118: 2846-2846. DOI: 10.1182/Blood.V118.21.2846.2846 |
0.445 |
|
| 2011 |
Zappasodi R, Cavanè A, Iorio MV, Tortoreto M, Ruggiero G, Magni M, Carlo-Stella C, Tagliabue E, Zunino F, Croce CM, Gianni AM, Di Nicola M. MiR-146a up-Regulation Is Associated with Anti-Tumor Activity of Pan-Histone Deacetylase Inhibitor ITF2357 (Givinostat®) in Human Burkitt's Lymphoma Blood. 118: 2729-2729. DOI: 10.1182/Blood.V118.21.2729.2729 |
0.477 |
|
| 2011 |
Basu A, Alder H, Khiyami A, Leahy P, Croce CM, Haldar S. MicroRNA-375 and microRNA-221: Potential noncoding RNAs associated with antiproliferative activity of Benzyl isothiocyanate in pancreatic cancer Genes and Cancer. 2: 108-119. DOI: 10.1177/1947601911409212 |
0.486 |
|
| 2011 |
Fanini F, Vannini I, Fernandez-Cymering C, Volinia S, Ridolfi L, Palatini J, Casadio V, Arienti C, Ulivi P, Zoli W, Amadori D, Croce CM, Fabbri M. Abstract LB-347: A microRNA signature harbors prognostic implications in clear cell renal carcinoma (ccRC) Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-347 |
0.484 |
|
| 2011 |
Park JK, Kogure T, Nuovo GJ, He L, Kim JH, Phelps MA, Croce CM, Patel T, Schmittgen TD. Abstract 4711: Silencing of miR-221 with anti-microRNA oligonucleotides is an effective therapeutic for hepatocellular carcinoma Cancer Research. 71: 4711-4711. DOI: 10.1158/1538-7445.Am2011-4711 |
0.441 |
|
| 2011 |
Motiwala T, Datta J, Kutay H, Roy S, Checovich A, Zanesi N, Kaou M, Johnson A, Hagan J, Byrd JC, Croce CM, Jacob ST. Abstract 276: Role of AP1 elements and TCL1 protein in regulation of the gene encoding PTPROt (protein tyrosine phosphatase receptor-type O) in chronic lymphocytic leukemia Cancer Research. 71: 276-276. DOI: 10.1158/1538-7445.Am2011-276 |
0.359 |
|
| 2011 |
Efanov AA, Palamarchuk A, Zanesi N, Nazaryan N, Croce CM, Pekarsky Y. Abstract 2185: DLEU7 is a putative tumor suppressor in glioblastoma Cancer Research. 71: 2185-2185. DOI: 10.1158/1538-7445.Am2011-2185 |
0.323 |
|
| 2011 |
Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Battaglia G, Balistreri M, Croce CM, Zaninotto G, Ancona E, Rugge M. Abstract 156: MicroRNA expression profiling of human esophageal metaplastic changes Cancer Research. 71: 156-156. DOI: 10.1158/1538-7445.Am2011-156 |
0.484 |
|
| 2011 |
Hudson RS, Yi M, Esposito D, Stephens RM, Croce CM, Ambs S. Abstract 140: Tumor suppressor role of microRNA-1 in prostate cancer Cancer Research. 71: 140-140. DOI: 10.1158/1538-7445.Am2011-140 |
0.438 |
|
| 2011 |
Basu A, Alder H, Khiyami A, Leahy P, Croce CM, Haldar S. Abstract 139: MicroRNA-375 and microRNA-221: Potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer Cancer Research. 71: 139-139. DOI: 10.1158/1538-7445.Am2011-139 |
0.505 |
|
| 2011 |
Braconi C, Kogure T, Valeri N, Nuovo G, Costinean S, Croce CM, Patel T. Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC) Cancer Research. 71: 1178-1178. DOI: 10.1158/1538-7445.Am2011-1178 |
0.45 |
|
| 2011 |
Boeri M, Verri C, Roz L, Conte D, Modena P, Facchinetti F, Croce CM, Sozzi G, Pastorino U. Abstract 1162: MicroRNA expression profiles of tumors, normal lung tissues and plasma samples from spiral-computed tomography (CT) trial for early lung cancer detection Cancer Research. 71: 1162-1162. DOI: 10.1158/1538-7445.Am2011-1162 |
0.421 |
|
| 2011 |
Quintavalle C, Garofalo M, Romano G, Iaboni M, Donnarumma E, Nuovo G, Croce CM, Condorelli G. Abstract 1151: microRNAs affect therapeutic sensitivity of human gliobastoma to temozolomide Cancer Research. 71: 1151-1151. DOI: 10.1158/1538-7445.Am2011-1151 |
0.481 |
|
| 2011 |
Fenger JM, Volinia S, Palatini J, Valli VE, Croce CM, Kisseberth WC. Abstract 1143: Deep sequencing of microRNAs in canine diffuse large B-cell lymphoma Cancer Research. 71: 1143-1143. DOI: 10.1158/1538-7445.Am2011-1143 |
0.449 |
|
| 2011 |
Ryan BM, Robinson D, Calhoun K, Robles AI, Valeri N, Croce C, Harris CC. Abstract B61: Insights into lung cancer survival in African Americans from a study of germline variation in the microRNA network Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B61 |
0.318 |
|
| 2011 |
Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Battaglia G, Balistreri M, Croce CM, Zaninotto G, Ancona E, Rugge M. MicroRNA Expression Profiling of Human Esophageal Metaplastic Changes Gastroenterology. 140: S-669. DOI: 10.1016/S0016-5085(11)62776-5 |
0.344 |
|
| 2010 |
Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, Terracciano L, Croce CM, Patel T. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 108: 786-91. PMID 21187392 DOI: 10.1073/Pnas.1011098108 |
0.362 |
|
| 2010 |
Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM. MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proceedings of the National Academy of Sciences of the United States of America. 107: 21098-103. PMID 21078976 DOI: 10.1073/Pnas.1015541107 |
0.478 |
|
| 2010 |
Cairo S, Wang Y, de Reyniès A, Duroure K, Dahan J, Redon MJ, Fabre M, McClelland M, Wang XW, Croce CM, Buendia MA. Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proceedings of the National Academy of Sciences of the United States of America. 107: 20471-6. PMID 21059911 DOI: 10.1073/Pnas.1009009107 |
0.437 |
|
| 2010 |
Fedele M, Visone R, De Martino I, Palmieri D, Valentino T, Esposito F, Klein-Szanto A, Arra C, Ciarmiello A, Croce CM, Fusco A. Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. European Journal of Cancer (Oxford, England : 1990). 47: 470-8. PMID 21044834 DOI: 10.1016/J.Ejca.2010.09.045 |
0.328 |
|
| 2010 |
Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proceedings of the National Academy of Sciences of the United States of America. 107: 19879-84. PMID 20980664 DOI: 10.1073/Pnas.1007698107 |
0.403 |
|
| 2010 |
de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia S, Croce CM, Najmabadi H, Diederichs S, Sahin O, Mayer D, Lyko F, Hoheisel JD, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Research. 70: 9175-84. PMID 20978187 DOI: 10.1158/0008-5472.Can-10-1318 |
0.489 |
|
| 2010 |
Nana-Sinkam SP, Fabbri M, Croce CM. MicroRNAs in cancer: personalizing diagnosis and therapy. Annals of the New York Academy of Sciences. 1210: 25-33. PMID 20973796 DOI: 10.1111/J.1749-6632.2010.05822.X |
0.41 |
|
| 2010 |
Thompson LH, Whiston RA, Rakhimov Y, Taccioli C, Liu CG, Croce C, Metcalfe SM. A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor Cell Cycle. 9: 4213-4221. PMID 20962578 DOI: 10.4161/Cc.9.20.13543 |
0.441 |
|
| 2010 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, ... ... Croce CM, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 18: 367-81. PMID 20951946 DOI: 10.1016/J.Ccr.2010.09.005 |
0.793 |
|
| 2010 |
Pekarsky Y, Croce CM. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget. 1: 224-227. PMID 20936047 DOI: 10.18632/Oncotarget.129 |
0.44 |
|
| 2010 |
Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nature Reviews. Drug Discovery. 9: 775-89. PMID 20885409 DOI: 10.1038/Nrd3179 |
0.411 |
|
| 2010 |
Pekarsky Y, Zanesi N, Croce CM. Molecular basis of CLL. Seminars in Cancer Biology. 20: 370-6. PMID 20863894 DOI: 10.1016/J.Semcancer.2010.09.003 |
0.38 |
|
| 2010 |
Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 29: 6390-401. PMID 20802525 DOI: 10.1038/Onc.2010.361 |
0.368 |
|
| 2010 |
Nuovo GJ, Wu X, Volinia S, Yan F, di Leva G, Chin N, Nicol AF, Jiang J, Otterson G, Schmittgen TD, Croce C. Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 19: 135-43. PMID 20736742 DOI: 10.1097/Pdm.0B013E3181C4Daaa |
0.709 |
|
| 2010 |
Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, Liu CG, Croce C, Calin GA, Esteller M. Disrupted microrna expression caused by Mecp2 loss in a mouse model of Rett syndrome Epigenetics. 5: 656-663. PMID 20716963 DOI: 10.4161/Epi.5.7.13055 |
0.453 |
|
| 2010 |
Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Research. 38: 7673-88. PMID 20639536 DOI: 10.1093/Nar/Gkq637 |
0.483 |
|
| 2010 |
Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N, Croce CM. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochemical Pharmacology. 80: 2057-65. PMID 20637737 DOI: 10.1016/J.Bcp.2010.07.003 |
0.456 |
|
| 2010 |
Chan KK, Liu Z, Xie Z, Chiu M, Wang H, Chen P, Dunkerson S, Chiu M, Liu S, Triantafillou G, Garzon R, Croce CM, Byrd JC, Muthusamy N, Marcucci G. A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application. The Aaps Journal. 12: 556-68. PMID 20625866 DOI: 10.1208/S12248-010-9214-0 |
0.396 |
|
| 2010 |
Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis. 31: 1561-6. PMID 20622002 DOI: 10.1093/Carcin/Bgq143 |
0.421 |
|
| 2010 |
Almanza G, Fernandez A, Volinia S, Cortez-Gonzalez X, Croce CM, Zanetti M. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. Plos One. 5: e11243. PMID 20582165 DOI: 10.1371/Journal.Pone.0011243 |
0.345 |
|
| 2010 |
Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Research. 70: 5184-93. PMID 20501828 DOI: 10.1158/0008-5472.Can-10-0145 |
0.415 |
|
| 2010 |
Iorio MV, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: An intricate network Biochimica Et Biophysica Acta - Gene Regulatory Mechanisms. 1799: 694-701. PMID 20493980 DOI: 10.1016/J.Bbagrm.2010.05.005 |
0.387 |
|
| 2010 |
Di Leva G, Croce CM. Roles of small RNAs in tumor formation Trends in Molecular Medicine. 16: 257-267. PMID 20493775 DOI: 10.1016/J.Molmed.2010.04.001 |
0.728 |
|
| 2010 |
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, ... ... Croce CM, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Research. 20: 589-99. PMID 20439436 DOI: 10.1101/Gr.098046.109 |
0.752 |
|
| 2010 |
Nana-Sinkam P, Croce CM. MicroRNAs in diagnosis and prognosis in cancer: what does the future hold? Pharmacogenomics. 11: 667-669. PMID 20415558 DOI: 10.2217/Pgs.10.57 |
0.436 |
|
| 2010 |
Cohn DE, Fabbri M, Valeri N, Alder H, Ivanov I, Liu CG, Croce CM, Resnick KE. Comprehensive miRNA profiling of surgically staged endometrial cancer. American Journal of Obstetrics and Gynecology. 202: 656.e1-8. PMID 20400061 DOI: 10.1016/J.Ajog.2010.02.051 |
0.364 |
|
| 2010 |
Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. Journal of the National Cancer Institute. 102: 706-21. PMID 20388878 DOI: 10.1093/Jnci/Djq102 |
0.698 |
|
| 2010 |
Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C, Iaboni M, Nuovo G, Croce CM, Condorelli G. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Research. 70: 3638-46. PMID 20388802 DOI: 10.1158/0008-5472.Can-09-3341 |
0.456 |
|
| 2010 |
Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri L, Bolondi L, Lanza G, Querzoli P, Angioni A, Croce CM, et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Research. 70: 3140-9. PMID 20388800 DOI: 10.1158/0008-5472.Can-09-4456 |
0.459 |
|
| 2010 |
Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, Radmacher MD, Li C, Whitman SP, Mishra A, Stauffer N, ... ... Croce CM, et al. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell. 17: 333-47. PMID 20385359 DOI: 10.1016/J.Ccr.2010.03.008 |
0.399 |
|
| 2010 |
Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S, Liu S, Havelange V, Becker H, Schaaf L, Mickle J, Devine H, Kefauver C, Devine SM, Chan KK, ... ... Croce CM, et al. Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine. Proceedings of the National Academy of Sciences of the United States of America. 107: 7473-8. PMID 20368434 DOI: 10.1073/Pnas.1002650107 |
0.339 |
|
| 2010 |
Efanov A, Zanesi N, Nazaryan N, Santanam U, Palamarchuk A, Croce CM, Pekarsky Y. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. Leukemia. 24: 970-5. PMID 20357824 DOI: 10.1038/Leu.2010.46 |
0.338 |
|
| 2010 |
Hertlein E, Wagner AJ, Jones J, Lin TS, Maddocks KJ, Towns WH, Goettl VM, Zhang X, Jarjoura D, Raymond CA, West DA, Croce CM, Byrd JC, Johnson AJ. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood. 116: 45-53. PMID 20351313 DOI: 10.1182/Blood-2010-01-263756 |
0.307 |
|
| 2010 |
Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, ... ... Croce CM, et al. Modulation of mismatch repair and genomic stability by miR-155. Proceedings of the National Academy of Sciences of the United States of America. 107: 6982-7. PMID 20351277 DOI: 10.1073/Pnas.1002472107 |
0.319 |
|
| 2010 |
Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, ... Croce CM, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Research. 70: 2789-98. PMID 20332227 DOI: 10.1158/0008-5472.Can-09-3541 |
0.409 |
|
| 2010 |
Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Castelli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Croce CM, Fontana L, Peschle C. Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica. 95: 1253-60. PMID 20305142 DOI: 10.3324/Haematol.2009.018259 |
0.429 |
|
| 2010 |
Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, ... ... Croce CM, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 140: 652-65. PMID 20211135 DOI: 10.1016/J.Cell.2010.01.007 |
0.403 |
|
| 2010 |
Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 957-66. PMID 20103677 DOI: 10.1158/1078-0432.Ccr-09-2123 |
0.328 |
|
| 2010 |
Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L, Kipps T, Croce CM, Pekarsky Y. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood. 115: 3916-22. PMID 20071661 DOI: 10.1182/Blood-2009-10-249367 |
0.445 |
|
| 2010 |
Izzotti A, Calin GA, Steele VE, Cartiglia C, Longobardi M, Croce CM, De Flora S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prevention Research (Philadelphia, Pa.). 3: 62-72. PMID 20051373 DOI: 10.1158/1940-6207.Capr-09-0202 |
0.349 |
|
| 2010 |
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. miR-221 overexpression contributes to liver tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 264-9. PMID 20018759 DOI: 10.1073/Pnas.0907904107 |
0.452 |
|
| 2010 |
Pallante P, Visone R, Croce CM, Fusco A. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocrine-Related Cancer. 17: F91-104. PMID 19942715 DOI: 10.1677/Erc-09-0217 |
0.349 |
|
| 2010 |
Volinia S, Visone R, Galasso M, Rossi E, Croce CM. Identification of microRNA activity by Targets' Reverse EXpression Bioinformatics. 26: 91-97. PMID 19897564 DOI: 10.1093/Bioinformatics/Btp598 |
0.4 |
|
| 2010 |
Stein GS, Stein JL, Van Wijnen AJ, Lian JB, Montecino M, Croce CM, Choi JY, Ali SA, Pande S, Hassan MQ, Zaidi SK, Young DW. Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer. Advances in Enzyme Regulation. 50: 160-7. PMID 19896493 DOI: 10.1016/J.Advenzreg.2009.10.026 |
0.358 |
|
| 2010 |
Sanchez-Aguilera A, Rattmann I, Drew DZ, Müller LU, Summey V, Lucas DM, Byrd JC, Croce CM, Gu Y, Cancelas JA, Johnston P, Moritz T, Williams DA. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia. 24: 97-104. PMID 19847197 DOI: 10.1038/Leu.2009.217 |
0.352 |
|
| 2010 |
Vecchione A, Croce CM. Apoptomirs: Small molecules have gained the license to kill Endocrine-Related Cancer. 17. PMID 19815577 DOI: 10.1677/Erc-09-0163 |
0.432 |
|
| 2010 |
Giarnieri E, Zanesi N, Bottoni A, Alderisio M, Lukic A, Vecchione A, Ziparo V, Croce CM, Mancini R. Oncosuppressor proteins of fragile sites are reduced in cervical cancer. Cancer Letters. 289: 40-5. PMID 19700237 DOI: 10.1016/J.Canlet.2009.07.017 |
0.332 |
|
| 2010 |
Sandhu S, Neinast R, Balatti V, Lovat F, Volinia S, Garzon R, Pekarsky Y, Croce CM. B-Cell Lymphoma In Eu-Mir-17~92 Transgenic Mice Blood. 116: 774-774. DOI: 10.1182/Blood.V116.21.774.774 |
0.49 |
|
| 2010 |
Ma W, Davis RE, Jacamo R, Konopleva M, Garzon R, Croce CM, Andreeff M. Mesenchymal Stromal Cells From AML Bone Marrow Are Abnormal by Gene Expression Profiling. Blood. 116: 1055-1055. DOI: 10.1182/Blood.V116.21.1055.1055 |
0.303 |
|
| 2010 |
Santanam U, Zanesi N, Efanov A, Palamarchuk A, Costinean S, Hagan J, Croce C, Pekarsky Y. Abstract LB-352: B-CLL phenotype in Eµ-miR-29 transgenic mice Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-352 |
0.394 |
|
| 2010 |
Quintavalle C, Garofalo M, Romano G, Iaboni M, Zanca C, Brenca M, Nuovo G, Croce CM, Condorelli G. Abstract LB-351: miR-221&222 regulate cell motility in glioma cell lines targeting the protein phosphates PTPμ Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-351 |
0.488 |
|
| 2010 |
Wan S, Taccioli C, Chen H, Jiang Y, Liu X, Croce CM, Farber JL, Fong LYY. Abstract 4174: Cxcl5 and Cxcl2 overexpression in esophageal carcinogenesis is associated with rapid tumor formation in zinc-deficient rats Cancer Research. 70: 4174-4174. DOI: 10.1158/1538-7445.Am10-4174 |
0.353 |
|
| 2010 |
Braconi C, Kogure T, Valeri N, Huang N, Gasparini P, Nuovo G, Terracciano L, Croce CM, Patel T. Abstract 4086: Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth Cancer Research. 70: 4086-4086. DOI: 10.1158/1538-7445.Am10-4086 |
0.345 |
|
| 2010 |
Visone R, Veronese A, Rassenti LZ, Balatti V, Taccioli C, Kipps TJ, Croce CM. Abstract 4051: MiR-181b expression levels decreases during the progression of the Chronic Lymphocytic Leukemia: a new potential prognostic tool Cancer Research. 70: 4051-4051. DOI: 10.1158/1538-7445.Am10-4051 |
0.429 |
|
| 2010 |
Efanov AA, Zanesi N, Maximov V, Nazaryan N, Santanam U, Palamarchuk A, Croce CM, Pekarsky Y. Abstract 401: CD5+CD23+ leukemic cell populations in Tcl1 transgenic mice show significantly increased proliferation and Akt phosphorylation Cancer Research. 70: 401-401. DOI: 10.1158/1538-7445.Am10-401 |
0.338 |
|
| 2010 |
Schetter AJ, Nguyen GH, Hawkes JE, Sohn JJ, Bowman ED, Leung SY, Croce CM, Harris CC. Abstract 3053: Associations of microRNA-34a, −34b, and −34c expression with p53 status, diagnosis, and prognosis in colon and adenocarcinoma Cancer Research. 70: 3053-3053. DOI: 10.1158/1538-7445.Am10-3053 |
0.46 |
|
| 2010 |
Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, Clemente R, Rizzetto C, Croce CM, Zaninotto G, Ancona E, Rugge M. Abstract 3050: MicroRNA expression profiling of human Barrett's carcinogenesis Cancer Research. 70: 3050-3050. DOI: 10.1158/1538-7445.Am10-3050 |
0.491 |
|
| 2010 |
Sozzi G, Boeri M, Roz L, Conte D, Modena P, Facchinetti F, Croce CM, Pastorino U. Abstract 3021: MicroRNA expression profile of CT screening detected lung cancer Cancer Research. 70: 3021-3021. DOI: 10.1158/1538-7445.Am10-3021 |
0.496 |
|
| 2010 |
Budhu AS, Yu Z, Forgues M, Tang ZY, Croce CM, Wang XW. Abstract 3003: Immune cell-related microRNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma Cancer Research. 70: 3003-3003. DOI: 10.1158/1538-7445.Am10-3003 |
0.44 |
|
| 2010 |
Sandhu SK, Costinean S, Neinast R, Parthun M, Garzon R, Croce C. Abstract 3: OncomiR-155 targets oncogenes HDAC4 and BCL6 in a murine B cell leukemia model: A paradigm shift in the oncogenic mechanisms of microRNAs Cancer Research. 70: 3-3. DOI: 10.1158/1538-7445.Am10-3 |
0.495 |
|
| 2010 |
Iorio MV, Piovan C, Leva GD, Casalini P, Tortoreto M, Plantamura I, Taccioli C, Croce CM, Tagliabue E. Abstract 2089: MiR-205 role in triple negative breast cancer Cancer Research. 70: 2089-2089. DOI: 10.1158/1538-7445.Am10-2089 |
0.473 |
|
| 2010 |
Veronese A, Consiglio J, Visone R, Zanesi N, Ferracin M, Lanza G, Querzoli P, Angioni A, Croce C, Negrini M. Abstract 2087: miR-483-3p is an oncogene involved in nephroblastoma and in adult tumors with activated β-catenin Cellular and Molecular Biology. 70: 2087-2087. DOI: 10.1158/1538-7445.Am10-2087 |
0.381 |
|
| 2010 |
Eiring AM, Harb J, Neviani P, Oaks JJ, Liu S, Spizzo R, Schwind S, Santhanam R, Hickey C, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, ... ... Croce CM, et al. Abstract 1950: Suppression of RISC-independent decoy and RISC-mediated RNA-pairing activities of microRNA-328 is required for maturation-arrest and enhanced survival of blast crisis CML progenitors Cancer Research. 70: 1950-1950. DOI: 10.1158/1538-7445.Am10-1950 |
0.458 |
|
| 2010 |
Zappasodi R, Iorio M, Cavanè A, Magni M, Ruggiero G, Carlo-Stella C, Croce C, Gianni A, Nicola MD. 537 Potent in vitro and in vivo anti-tumor activity of ITF2357 by modulation of c-myc related miRNA signature in human Burkitt's lymphoma European Journal of Cancer Supplements. 8: 171. DOI: 10.1016/S1359-6349(10)72244-8 |
0.364 |
|
| 2010 |
Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, Clemente R, Rizzetto C, Croce CM, Zaninotto G, Ancona E, Rugge M. 187 MicroRNA Expression Profiling of Human Barrett's Carcinogenesis Gastroenterology. 138: S-34. DOI: 10.1016/S0016-5085(10)60158-8 |
0.348 |
|
| 2010 |
Bloomston M, Wojcik S, Collins A, Croce C. Hypozia Inducible Factor 1-A (HIF-1α) Upregulates MicroRNA-21 (miR-21) in Pancreatic Cancer Journal of Surgical Research. 158: 403. DOI: 10.1016/J.Jss.2009.11.643 |
0.402 |
|
| 2009 |
Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, ... ... Croce CM, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. The Lancet. Oncology. 11: 136-46. PMID 20022810 DOI: 10.1016/S1470-2045(09)70343-2 |
0.372 |
|
| 2009 |
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, ... Croce CM, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 16: 498-509. PMID 19962668 DOI: 10.1016/J.Ccr.2009.10.014 |
0.798 |
|
| 2009 |
Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM, Calin GA. Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis. 31: 208-15. PMID 19926640 DOI: 10.1093/Carcin/Bgp209 |
0.379 |
|
| 2009 |
Iorio MV, Croce CM. MicroRNAs in cancer: Small molecules with a huge impact Journal of Clinical Oncology. 27: 5848-5856. PMID 19884536 DOI: 10.1200/Jco.2009.24.0317 |
0.439 |
|
| 2009 |
Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood. 114: 5331-41. PMID 19850741 DOI: 10.1182/Blood-2009-03-211938 |
0.45 |
|
| 2009 |
Zaidi SK, Dowdy CR, van Wijnen AJ, Lian JB, Raza A, Stein JL, Croce CM, Stein GS. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Research. 69: 8249-55. PMID 19826043 DOI: 10.1158/0008-5472.Can-09-1567 |
0.433 |
|
| 2009 |
Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, et al. MicroRNA expression, survival, and response to interferon in liver cancer. The New England Journal of Medicine. 361: 1437-47. PMID 19812400 DOI: 10.1056/Nejmoa0901282 |
0.313 |
|
| 2009 |
Tili E, Croce CM, Michaille JJ. miR-155: on the crosstalk between inflammation and cancer. International Reviews of Immunology. 28: 264-84. PMID 19811312 DOI: 10.1080/08830180903093796 |
0.446 |
|
| 2009 |
Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, Altorki NK, Casson AG, Liu CG, Wang XW, Yanaihara N, ... ... Croce CM, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6192-200. PMID 19789312 DOI: 10.1158/1078-0432.Ccr-09-1467 |
0.38 |
|
| 2009 |
Croce CM. Causes and consequences of microRNA dysregulation in cancer Nature Reviews Genetics. 10: 704-714. PMID 19763153 DOI: 10.1038/Nrg2634 |
0.42 |
|
| 2009 |
Calin GA, Croce CM. Chronic lymphocytic leukemia: Interplay between noncoding RNAs and protein-coding genes Blood. 114: 4761-4770. PMID 19745066 DOI: 10.1182/Blood-2009-07-192740 |
0.435 |
|
| 2009 |
Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5878-87. PMID 19737943 DOI: 10.1158/1078-0432.Ccr-09-0627 |
0.406 |
|
| 2009 |
Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GA. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death and Differentiation. 17: 246-54. PMID 19730444 DOI: 10.1038/Cdd.2009.117 |
0.431 |
|
| 2009 |
Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, Volinia S, Ferracin M, Palatini J, Balatti V, Alder H, Negrini M, Kipps TJ, Croce CM. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 114: 3872-9. PMID 19717645 DOI: 10.1182/Blood-2009-06-229211 |
0.436 |
|
| 2009 |
Wang B, Majumder S, Nuovo G, Kutay H, Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K, Jacob ST. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology (Baltimore, Md.). 50: 1152-61. PMID 19711427 DOI: 10.1002/Hep.23100 |
0.425 |
|
| 2009 |
Marcucci G, Mrózek K, Radmacher MD, Bloomfield CD, Croce CM. MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias. Best Practice & Research. Clinical Haematology. 22: 239-48. PMID 19698931 DOI: 10.1016/J.Beha.2009.05.003 |
0.376 |
|
| 2009 |
Havelange V, Garzon R, Croce CM. MicroRNAs: new players in acute myeloid leukaemia. British Journal of Cancer. 101: 743-8. PMID 19672257 DOI: 10.1038/Sj.Bjc.6605232 |
0.404 |
|
| 2009 |
Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, Sherman MH, Liu SJ, Dawson DW, Williams KE, Lanasa M, Liyanarachchi S, Lin TS, Marcucci G, Pekarsky Y, ... ... Croce CM, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 106: 13433-8. PMID 19666576 DOI: 10.1073/Pnas.0906455106 |
0.326 |
|
| 2009 |
Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A. MicroRNA expression profiling of male breast cancer. Breast Cancer Research : Bcr. 11: R58. PMID 19664288 DOI: 10.1186/Bcr2348 |
0.385 |
|
| 2009 |
Garofalo M, Condorelli GL, Croce CM, Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death and Differentiation. 17: 200-8. PMID 19644509 DOI: 10.1038/Cdd.2009.105 |
0.357 |
|
| 2009 |
Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annual Review of Medicine. 60: 167-79. PMID 19630570 DOI: 10.1146/annurev.med.59.053006.104707 |
0.325 |
|
| 2009 |
Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proceedings of the National Academy of Sciences of the United States of America. 106: 12085-90. PMID 19597153 DOI: 10.1073/Pnas.0905234106 |
0.431 |
|
| 2009 |
Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. The Journal of Pathology. 219: 214-21. PMID 19593777 DOI: 10.1002/Path.2586 |
0.481 |
|
| 2009 |
Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology (Baltimore, Md.). 50: 472-80. PMID 19585654 DOI: 10.1002/Hep.22989 |
0.442 |
|
| 2009 |
Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Research. 69: 5761-7. PMID 19584283 DOI: 10.1158/0008-5472.Can-08-4797 |
0.457 |
|
| 2009 |
Levati L, Alvino E, Pagani E, Arcelli D, Caporaso P, Bondanza S, Di Leva G, Ferracin M, Volinia S, Bonmassar E, Croce CM, D'Atri S. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. International Journal of Oncology. 35: 393-400. PMID 19578755 |
0.701 |
|
| 2009 |
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, ... Croce CM, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 5: 111-23. PMID 19570518 DOI: 10.1016/J.Stem.2009.06.008 |
0.351 |
|
| 2009 |
Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood. 114: 1374-82. PMID 19520806 DOI: 10.1182/Blood-2009-05-220814 |
0.422 |
|
| 2009 |
Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death and Differentiation. 17: 215-20. PMID 19498445 DOI: 10.1038/Cdd.2009.69 |
0.482 |
|
| 2009 |
Bloomston M, Kneile J, Butterfield M, Dillhoff M, Muscarella P, Ellison EC, Melvin WS, Croce CM, Pichiorri F, Huebner K, Frankel WL. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Annals of Surgical Oncology. 16: 2331-8. PMID 19434452 DOI: 10.1245/S10434-009-0507-4 |
0.339 |
|
| Show low-probability matches. |
